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Definition of key terms  
Active case finding The systematic screening of specific risk groups for the 
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High risk groups Any group of people with significantly higher TB incidence or 
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procedures that can be applied rapidly. Among those with 
suspected TB, the diagnosis needs to be established through the 
application of diagnostic tests and clinical assessment 
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Xpert MTB/RIF The examination of a sputum sample using the Xpert MTB/RIF 
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Abstract 
Background  
In South Africa, tuberculosis (TB) detection remains a major problem, as notified cases are 
estimated to account for only 68% of all incident cases. Health services have relied on 
passive case finding and this leads to missed or delayed diagnosis. In Cape Town, City 
Health has embarked on an active surveillance programme to systematically screen all adults 
seeking health care at PHC facilities for active TB, in order to identify undiagnosed incident 
TB cases and avert missed opportunities for treating TB.  
Aim 
The aim of this study was to evaluate the effects of an intensified TB screening strategy on 
changes in facility level TB case finding in City Health PHC facilities in Cape Town.  
Methodology 
The study design was a before-after study of changes in facility level TB case finding 
following implementation of an intensified TB screening strategy, by comparing data on 
patients screened and tested from the same facilities in 2015 and 2017.  The study population 
consisted of all patients ≥5 years seeking care at 82 City Health PHC facilities in Cape Town 
who were screened for active TB and registered in the PREHMIS TB Identification Registers 
in 2015 and 2017.  The TB cascade was analysed from screening to treatment initiation and 
disaggregated to sub-district and facility with the main outcome indicator defined as TB cases 
detected per 1,000 PHC headcount (Case detection rate). Multi-variate analysis was done to 
determine if there was an association of a diagnosis of active TB identified through the 
intensified TB screening strategy with individual patient variables and year of diagnosis. 
Permission was obtained from the City Health to access the data. A waiver of individual 
patient consent was obtained from the UWC Biomedical Research Ethics Committee.  
Results 
A total of 98,873 entries in PREHMIS were analysed. There was a 3.5 fold increase in the 
PHC headcount ≥5 years screened for TB symptoms in 2015 compared to 2017. Despite this, 
there was a 7.6% decline in numbers of recorded presumptive TB patients in the two years, as 
well as a 1.7% decline in the overall PHC headcount ≥5 years. The profile of presumptive 
patients remained the same. Of the patients who had a TB symptom screen performed, 22.9% 
screened positive for TB symptoms in 2015 compared to 5.9% in 2017. Overall, the number 
of patients with a positive sputum test declined by 9.2% over the two years and the number of 
patients initiated onto TB treatment declined by 7.2%. In 2015, one patient with active TB 
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disease was detected for every 29 patients screened. In 2017, one active TB patient was 
detected for every 116 patients screened.  Despite the increased screening, the case detection 
rate per 1,000 PHC headcount ≥5 years declined slightly from 4.0 in 2015 to 3.7 in 2017. 
There were wide disparities in case detection rates between the health sub-districts in 2015 
compared to 2017. Scatterplots showed no significant correlation between percentage PHC 
headcount ≥5 years screened for TB symptoms and case detection rate per 1,000 PHC 
headcount in the 82 PHC facilities in 2015 (r=0.064; p=0.568) or in 2017 (r=-0.124; 
p=0.268). Being male, HIV positive, history of previous TB treatment episodes and being a 
contact of a known drug resistant TB index case were all associated with a diagnosis of active 
TB disease on univariate and multivariate analysis. 
Conclusion 
Improving TB case detection together with earlier treatment initiation should contribute to 
reducing TB transmission. However, the key finding from this study is that the current 
strategy of “universal” screening did not increase TB case detection. Despite very big 
increases in reported screening rates, presumptive cases identified and overall case detection 
in fact decreased over the period. The data from individual facilities and sub-districts showed 
variable uptake rates but no consistent pattern (up or down) of presumptive or confirmed 
cases with increased screening. A limitation of the analysis is that without control groups, and 
in the context of declining TB incidence, it is not possible to say what the case detection rate 
would have been without the universal screening programme. However, taken together, the 
findings suggest that intensified TB screening in City Health TB clinics is ineffective, and 
other strategies of “universal testing” would need to be considered and further researched.  
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Chapter 1: Introduction  
1.1 Background 
Tuberculosis (TB) remains a major global health problem. The WHO Global Report (2017) 
reported that TB incidence is declining at about 2% per year and mortality at about 3% per 
year. In spite of the reported declining TB incidence rate, 6.3 million new cases of TB were 
reported in 2016 and it remains the leading cause of death from a single infectious agent, 
ranking above HIV/AIDS.  
The World Health Assembly adopted the End TB Strategy in May 2014, which aims to end 
the global TB epidemic by 2035 (WHO, 2015). Specific targets set in the End TB Strategy 
include a 90% reduction in TB deaths and an 80% reduction in TB incidence (new cases per 
year) between 2015 and 2030.  Both incidence and mortality need to decline at rates of 5% 
per annum respectively to reach the first milestones of the End TB Strategy.   
A key challenge to achieving these targets is that it is estimated that only two thirds of global 
infectious TB cases are notified, with the remaining one third of undiagnosed TB cases 
sustaining on going transmission of TB (WHO Global Report, 2017).  
In South Africa, TB incidence and mortality rates are following similar declining global 
trends with a  reported TB incidence rate of 781 per 100 000 population in 2016, down from 
834 per 100 000 population reported in 2015 (WHO Global TB Report, 2017). However, the 
current rate of decline is still too slow to meet the 2035 End TB Strategy targets. Despite a 
declining TB incidence rate, TB detection remains a major problem in South Africa, as 
notified cases are estimated to account for only 68% of all incident cases. This is below the 
WHO global target of detecting ≥70% of cases (WHO, 2016).  
The timeous provision of TB therapy to people diagnosed with TB leads to improved clinical 
outcomes (Golub et al., 2013). However, diagnosing tuberculosis disease (TB) is reliant on 
self-presentation of persons with TB symptoms to health care facilities and a high index of 
suspicion among health care workers (HCWs). Many people with active TB are 
asymptomatic in the early stages, are unlikely to seek care early and may not be properly 
diagnosed when seeking health care. This leads to missed or delayed diagnosis for infectious 
cases who still continue to transmit TB in the community. Current case detection levels may 
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be insufficient to detect enough cases of infectious TB to make an impact on the epidemic 
(Shapiro, 2013).  
Naidoo et al. (2017) undertook an analysis of the TB care cascade in South Africa, estimating 
the number and proportion of individuals with TB, who accessed tests, were diagnosed with 
TB, initiated treatment, and successfully completed treatment (Figure 1). Estimates were 
derived from national electronic TB register data, laboratory data, and published studies. The 
purpose was to enumerate losses in each step of the TB care cascade to inform appropriate 
programmatic responses and targeted interventions by the National TB Programme in South 
Africa, in order to meet the targets of the End TB Strategy.  
 
Figure 1 Tuberculosis Care Cascade in South Africa (copied from Naidoo et al., 2017)1 
 
 
Naidoo et al. (2017) estimated that only 5% of the estimated TB cases did not access testing. 
This small gap could possibly be attributed to patients having access to TB diagnostic 
services through the wide network of free public primary health care facilities in South 
Africa. However, in spite of this estimated small gap in the proportion of TB cases not 
accessing testing, empirical evidence from recent studies in South Africa suggests that there 
are still numerous missed opportunities at primary health care (PHC) facilities to test patients 
for TB. In these studies, more than three quarters of patients reporting their TB symptoms to 
                                                             
1 Incidence estimates for South Africa, which are based on case notification data and expert opinion on case 
detection gaps. The proportion at each step of the cascade is expressed in relation to the estimated burden. 
Note: The wide confidence interval for the tuberculosis burden reflects the World Health Organization 
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health care workers (HCWs) were not tested (Chihota et. al, 2015). A significant proportion 
may have culture positive TB (Claassens et al., 2013).  The South African government is 
committed to improving TB control, and has considered the most strategic, easily scalable, 
and locally contextualized solutions to achieve progress towards the WHO End TB goals. 
One of the strategies defined under the Find-Treat-Prevent framework is to reduce TB 
incidence and mortality by improving TB case-finding (NTP Strategic Plan, 2017).  
The End TB Strategy (2015) advocates systematic screening of high-risk groups for active 
disease to improve early case detection, as early detection helps to reduce the risks of TB 
transmission.  Modelling has shown that increased screening of all PHC facility attendees for 
TB disease (active surveillance) may have a substantial epidemiological impact. WHO 
(2013:19)  defines the  systematic screening for active TB “as the systematic identification of 
people with suspected active TB, in a predetermined target group, using tests, examinations 
or other procedures that can be applied rapidly. Among those with suspected TB, the 
diagnosis needs to be established through the application of diagnostic tests and clinical 
assessment.” Patient initiated pathways to a TB diagnosis can thus be complemented by 
screening, by asking all people who seek care in a health facility if they have any TB 
symptoms. The identification of TB symptoms is the first step in provider initiated screening 
for TB.  
In an implementation study in a busy PHC clinic in an informal settlement in Johannesburg, 
researchers prospectively evaluated a model for systematic TB symptom screening and HIV 
counselling and testing (HCT) for all adult clients attending the facility (Van Rie et al., 2014). 
During the 6 month implementation phase, 89.6% of all clinic attendees were screened for 
TB symptoms, of whom 14% had a positive TB symptom screen. The findings of this study 
suggest that systematic screening and appropriate testing in PHC facilities is effective in 
increasing TB case finding and may be an affordable and sustainable first step to increase 
case finding in high burden settings.  
A recent study conducted in outpatient departments in Ghana compared the yield of TB cases 
using different screening approaches (Ohene et al., 2017). Two symptom based TB screening 
protocols, with varying cough duration were implemented with general outpatients, people 
living with HIV (PLWH), diabetics and contacts. The yield of TB cases per 100,000 
population screened was highest among PLHIV, contacts, and diabetics. The findings of this 
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study suggest that more sensitive methods of  screening based on risk factors is effective in 
increasing TB case finding in health facilities. 
The findings from these studies suggest that systematic screening and appropriate testing in 
PHC facilities is effective in increasing TB case finding. In addition, for such opportunities to 
result in increased TB case-findings, symptom screening needs to be actively followed up 
with sputum testing (Khan, 2009).  
1.2 Study Setting 
Cape Town has a population of just over 4 million people (Census 2011). Only 24% of the 
population is insured for health care. The uninsured population are reliant on public health 
services offered by City Health and Metro District Health Service (MDHS) of the Western 
Cape Government (WCG). All PHC services are provided free of charge. City Health and 
MDHS jointly provide primary health care services in eight sub-districts with City Health 
responsible for managing 86 and MDHS 44 fixed PHC facilities (Table 1). City Health 
provides preventive care, reproductive health, TB, HIV and STI services, curative services to 
children <13years of age and curative and chronic disease services to adults at a limited 
number of facilities.  MDHS provides preventive care, reproductive health, TB, HIV and STI 
services, curative and chronic disease services to adults and curative services at a limited 
number of facilities to children <13years of age.  TB diagnostic services are available in all 
PHC facilities of both City Health and MDHS.  
 
Table 1 Package of services rendered by City Health & MDHS 
 City Health MDHS 
Child health 81 14 
Reproductive health 86 44 
STI 86 44 
Adult curative 12 44 
TB diagnostic 86 44 
TB treatment 85 24 
HIV testing 86 44 
ART 59 33 
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In Cape Town, City Health have embarked on an active surveillance programme and set a 
target to systematically screen 50% of all adults seeking health care at PHC facilities for 
active TB disease. The purpose of screening all patients attending PHC facilities is to try and 
identify undiagnosed incident TB cases and avert missed opportunities for treating TB. 
Specific TB screening stickers were printed with the WHO recommended four-symptom TB 
screen and were distributed with an implementation guideline, to all PHC facilities in 2016 
(Appendix 1).  
1.3 Problem Statement  
WHO guidelines on systematic screening for TB (2013:11) state that there is strong evidence 
that in settings with high TB prevalence in the general population, systematic screening for 
active TB should be considered amongst all people who seek health care, and that people 
living with HIV should be systematically screened for active TB at each visit to a health 
facility. Increased screening of PHC facility attendees for TB may have the greatest 
epidemiological impact and should reduce diagnostic delay, which in turn, reduces on-going 
transmission. Protocols and procedures have been implemented to systematically screen 
people living with HIV for active TB at each visit to a health facility.  However, the 
additional value of screening all other patients attending PHC services for other preventive 
and curative services is not known. 
1.4 Purpose of the Study  
The purpose of this study is to evaluate if the strategy implemented by City Health to 
systematically screen all people who seek health care at PHC facilities for active TB disease 
has translated into increased TB case finding and averted missed opportunities to diagnose 
TB.  
The findings of this study will shed light on the effectiveness, feasibility and sustainability of 
routine TB screening programmes in PHC facilities and can be used to influence future 
design of policy and implementation practices.  The findings of this study can also be used by 
local health managers to improve screening and testing at identified facilities with poor 
screening and those where symptomatic patients are not being tested for TB. 
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Chapter 2: Literature Review   
2.1 Introduction 
This chapter reviews available evidence that supports WHO Screening Guidelines (2013) 
recommendations that in settings with high TB prevalence in the population, systematic 
screening for active TB should be considered amongst a number of population groups. These 
groups are: people who are seeking health care or who are in health care; who belong to 
selected risk groups (e.g. HIV infection); those with close contacts of people with TB; and 
other subpopulations that have very poor access to health care. The rationale is that an 
increase in TB screening of all adults attending PHC facilities will translate into increased TB 
testing, diagnosis and treatment of undiagnosed incident cases and avert missed opportunities 
to diagnose TB.   
Most people who develop TB can be cured, with a timely diagnosis and correct treatment 
(Shapiro, 2013). In the absence of effective vaccines, the principal public health approach to 
TB control has been passive case finding, which is the detection of TB cases from those self-
presenting to health facilities with symptoms suggestive of TB (Uplekar et al., 2013). Whilst 
the approach of passive case finding combined with better treatment has contributed to 
improvements, the overall epidemiological impact has been inadequate, with case detection 
trends stagnating and TB incidence rates declining at rates far lower than expected (Lonnroth 
et al., 2013). Several explanations have been offered for the low case-detection rate, 
including poor health seeking behaviour of patients with respiratory symptoms; poor access 
to primary health care; delays in providing a diagnosis once the patient presents at a health 
service and the non-availability of appropriate tests and treatment (Davis et al., 2011). These 
observations have prompted more active approaches to early TB case detection, focusing on 
“active’’ case-finding strategies, which target high-risk groups.  
WHO (2013) has produced recommendations on systematic screening for active TB which 
set out principles and guidance for prioritisation of risk groups for screening. Systematic 
screening for active TB is predominantly provider-initiated and targets people who do not 
seek health care because they do not have or recognize symptoms or they do not perceive that 
they have a health problem that warrants medical attention, or there are barriers to accessing 
care, or for other reasons. It may also target people seeking routine health care who do or do 
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not have symptoms or signs compatible with TB and who may not be identified by “passive 
case-finding” as possibly having TB (WHO, 2013). 
The End TB Strategy (2015) advocates systematic screening of high-risk groups for active 
disease to improve early case detection, as early detection helps to reduce the risks of TB 
transmission.  A TB risk group may be defined as any group of people with significantly 
higher TB incidence or prevalence than the general population. A risk group may be a group 
of people sharing a specific individual-level risk factor (e.g., HIV infection), or people living 
in a specific geographical location (e.g., urban slum) or institution (e.g., prison) associated 
with a high burden of TB (Lonnroth et al., 2013). For case detection to be effective, health-
care providers must first refer at-risk patients for TB testing, then ensure that referred patients 
complete testing, and finally make certain that patients with positive test results are notified 
as cases of TB and initiated on treatment (Davis et al., 2011). 
Modelling has shown that increased screening of all PHC facility attendees for TB disease in 
settings with high TB prevalence in the population may have a substantial epidemiological 
impact (WHO, 2015).  The End TB Strategy therefore advocates that: 1) all adult PHC 
facility attendees are screened for presence of a chronic cough (lasting longer than 2 weeks); 
2) all adult PHC facility attendees who present with symptoms suggestive of TB are tested 
for active TB disease; and 3) all those who test positive for TB are placed on appropriate TB 
treatment immediately.  
2.2 Evidence related to systematic screening for TB 
The objectives of active case finding are to diagnose and treat patients earlier, thereby 
reducing negative treatment outcomes, sequelae, and socioeconomic consequences, as well as 
reducing the period of infectiousness and therefore transmission (WHO, 2013). A range of 
context specific approaches across the globe have experimented with enhanced TB case 
detection through screening, ranging from introducing a screening element into passive case 
finding to implementing comprehensive outreach programmes. Studies in Zimbabwe (Corbett 
et al., 2010), Cambodia (Eang et al., 2012) and Brazil (Miller et al., 2010) have reported 
improved case detection and declining TB burden associated with more active screening. 
The tools available to TB programmes are symptom screening, chest x-rays and sputum 
testing and are crucial in ensuring the efficacy of systematic screening (Uplekar et al., 2013). 
Screening however, is inappropriate unless diagnostic and treatment services of sufficient 
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quality are available or can be made available in parallel with implementing screening 
initiatives (Lonnroth et al., 2013). TB screening tests are not intended to be diagnostic and are 
used to elicit responses of symptoms suggestive of TB. WHO (2011) recommend a four-
symptom TB screen: cough ≥2weeks, fever, night sweats, and weight loss. The absence of all 
four symptoms is considered a negative screen. The presence of any one of these four 
symptoms is considered a positive screen and those who report any one of the symptoms may 
have active TB and a diagnosis is established using additional diagnostic tests. Symptom 
questionnaires provide a quick and convenient way to identify individuals who then need 
investigation and have a high sensitivity when used to define presumptive TB among patients 
who present themselves to health-care facilities for investigation of ill-health (Corbett et al., 
2010). 
A systematic review published by Kranzer et al. (2013) assessed the evidence that screening 
for TB disease 1) increases the number of TB cases initiated on anti-tuberculosis treatment, 
2) identifies cases earlier in the course of disease, 3) reduces mortality and morbidity, and 4) 
impacts on TB epidemiology. Most of the studies included were observational studies with 
significant variations in the study populations, settings and screening approaches.  The review 
found that screening increased the number of new cases in the short term. However, in many 
settings, more than half of prevalent cases in the community remained undiagnosed. 
Screening tends to find cases earlier and with less severe disease, but this may be attributed to 
case finding studies using more sensitive diagnostic methods than are available to routine 
programmes, rather than the effects of the increased screening itself. There was insufficient 
evidence from the studies to indicate whether active screening impacted on epidemiology, 
such as TB prevalence.  
2.3 Screening for TB amongst people living with HIV 
TB and HIV are overlapping epidemics. TB is an important gateway to HIV care and TB is a 
major presenting opportunistic infection in the majority of HIV positive patients with low 
CD4 counts. International Standards for TB Care (2014) recommend that HIV testing should 
be done on all patients suspected of or with TB particularly in areas with high HIV 
prevalence. Two separate studies in India reported low rates of HIV testing amongst 
presumptive TB patients; where only 44.6% and 68.0% had a known HIV status and of 
whom 3.3% and 8% were HIV positive, in the two studies respectively (Palanivel et al., 2013 
& Kumar et al., 2017). 
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WHO guidelines on systematic screening for TB (2013) state that there is strong evidence for 
systematically screening people living with HIV (PLWH) for active TB at each visit to a 
health facility.  TB screening is recommended for people with HIV infection to facilitate 
early diagnosis and safe initiation of anti-retroviral therapy (ART) and isoniazid preventive 
therapy (IPT). 
In a meta-analysis, Kranzer et al. (2010) estimated that between 3.6% and 24.7% of HIV 
infected patients attending ART services in sub-Saharan Africa, who are screened during 
intensified case finding, receive a diagnosis of tuberculosis.  The results from three different 
facility level studies showing the prevalence of undiagnosed culture-positive TB amongst 
ART enrolees are shown in Table 2. In two studies conducted at ART clinics in South Africa, 
there were similarities in the rates of prevalent TB amongst patients, varying from 19-26% 
(Lawn et al., 2009 & Basset et al., 2010).  In another study conducted by Cain et al. (2010) in 
eight outpatient clinics in Cambodia, Thailand, and Vietnam, TB was diagnosed in 15% of all 
patients.  
Table 2 Prevalence of undiagnosed culture-positive TB in facility level studies from high HIV 
prevalent settings 
Author, year Country Population Participants 
n 
Culture +TB 
% 
Lawn, 2009 South Africa ART clinic 235 25.7 
Bassett, 2010 South Africa HIV clinic 825 19.0 
Cain, 2010 South East Asia ART clinic 1,724 15.5 
 
The findings of these studies support the International Standards for TB Care and WHO 
recommendations that HIV testing should be done on all patients suspected of or with TB and 
PLWH should be systematically screened for active TB at each visit to a health facility. 
2.4 Screening close contacts of TB index patients 
Close contacts of known TB index patients are a specific high risk group. WHO guidelines on 
systematic screening for TB (2013) state that there is strong evidence to support 
systematically screening all household and other close contacts of confirmed TB index cases 
for active disease. 
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Morrison et al. (2008) conducted a systematic review to determine case detection rates 
through household contact investigation. They found a yield for all TB of 4.5%; 
bacteriological confirmation in 2.3% and latent TB infection in 51.4% of contacts 
investigated.  
In a recent study conducted by Little et al. (2018) it was reported that symptom screening 
among household contacts had low sensitivity and specificity for active TB and found a TB 
prevalence of 3.9% amongst close household contacts tested. Kweza et al. (2018) reported 
that amongst presumptive TB patients who tested positive 7.7% reported a current contact 
and 18% reported a contact within the past year.  
Data from a study in Brazil suggested that the prevalence of TB infection and progression to 
active TB among household contacts exposed to drug sensitive and drug resistant cases were 
comparable, despite a longer duration of exposure of contacts to drug resistant TB index 
cases (Teixeira et al., 2001).  
These results suggest that contact investigation with testing merits serious consideration as a 
means to improve early case detection and decrease transmission of mycobacterium 
tuberculosis (MTB) in high-incidence areas as close contacts of known TB index patients are 
a specific high risk group.  
2.5 Facility based TB screening 
WHO guidelines on systematic screening for TB (2013) state a conditional recommendation 
that in settings where the TB prevalence is 100/100 000 population or higher, systematic 
screening for active TB may be considered among people who are seeking health care or are 
in health care. There have been a number of initiatives, in diverse settings such as general 
outpatient departments (OPD) in hospitals, specific (e.g. diabetic) OPD clinics, PHC facilities 
or private providers, to introduce systematic screening for TB within health facilities (Table 
3).  
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Table 3 Results from facility level studies on in-facility TB screening amongst patients seeking 
care 
Author, year Country Population Participants 
n 
TB Screen + 
n 
TB + 
n 
Berkowitz, 2018 South Africa Diabetic clinic 440 202 (45.9%) 13 (6.4%) 
Van Rie, 2014 South Africa PHC clinic 26,279 3287 (12.5%) 90 (2.7%) 
Uplekar, 2013 Swaziland Hospital OPD 251,867 14,998 (6.0%) 1,254 (8.3%) 
Uplekar, 2013 Afghanistan PHC clinic 889,120 22,228 (2.5%) 1,986 (8.9%) 
Uplekar, 2013 Pakistan Private providers 469,896 8,458 (1.8%) 2,416 (28.5%) 
Bloss, 2012 Botswana PHC clinic 11,779 926 (7.8%) 19 (2.0%) 
 
Results from studies conducted in settings with high TB prevalence in the general population 
have shown an increased prevalence of undiagnosed TB among people who seek health care. 
Uplekar et al. (2013) reported that in Afghanistan, 2.5% clinic attendees from 47 health 
facilities screened positive for TB symptoms and were tested with smear microscopy of 
which 8.9% were AFB positive.  Private providers and community lay workers screened 
patients attending 54 private clinics and one hospital in a project in Pakistan over a period of 
one year; 1.8% of attendees who screened positive for TB symptoms were tested and 28.5% 
had a bacteriologically confirmed TB diagnosis (Uplekar et al., 2013).  
Similarly, several studies conducted in high TB prevalence and high HIV burden southern 
African settings have shown an increased prevalence of undiagnosed TB amongst PHC 
facility attendees who were systematically screened for TB symptoms.  
In a study conducted in Swaziland, all patients attending 32 outpatient (OPD) departments at 
hospitals were systematically screened for TB symptoms before seeing a clinician. Of those 
screened, 6% screened positive for TB symptoms and were offered an Xpert MTB/ RIF test 
and 8.3% received a bacteriologically confirmed diagnosis of active TB disease (Uplekar et 
al., 2013).  
TB screening was implemented among adults at patient intake in five clinics in Botswana 
(Bloss et al., 2012). Amongst those screened for TB at intake, 7.8% screened positive and 2% 
were diagnosed with TB.  
The results from another study conducted at a PHC clinic in Cape Town highlighted the 
importance of screening for HIV and active TB in older population groups who are in health 
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care. The study found a 3.0% prevalence of active TB among diabetes mellitus patients; and 
of the prevalent TB cases, 53.9% had no TB symptoms and 61.5% were HIV co–infected 
(Berkowitz et al., 2018). 
Van Rie et al. (2014) prospectively evaluated a model for systematic TB symptom screening 
and HIV counselling and testing (HCT) for all adult clients attending the facility in a busy 
PHC clinic in an informal settlement in Johannesburg. During the 6 month implementation 
phase, 89.6% of all clinic attendees were screened for TB symptoms, of which 14% had a 
positive TB symptom screen. However, only 35% of those with a positive TB symptom 
screen had a sputum specimen collected for testing and of these 8% had a bacteriologically 
confirmed result. In order to identify one case with active TB disease, 262 clients needed to 
be screened.  
The findings from these studies suggest routine that TB screening in health facilities is 
effective in increasing TB case finding, supporting the WHO conditional recommendation of 
systematically screening people who seek health care. However, with the exception of Van 
Rie et al. (2014), none of the studies evaluated and reported sustainability of screening in the 
long term. Van Rie et al. (2014) reported significantly lower proportions of clients screened 
for TB symptoms 6 and 12 months after initiation of the programme, highlighting the 
difficulties of implementing and sustaining TB screening in real-life settings.  
2.5.1 Different screening approaches to active TB case finding in facility based TB 
screening 
Uplekar et al. (2013) has recommended that choices of screening and diagnostic algorithms 
be based on the profile of the prioritised risk groups, the TB prevalence in the risk groups, the 
availability of tests, the capacity of diagnostic facilities and feasibility of using different tests 
in context of screening. 
In Ghana, two symptom based TB screening approaches of varying cough duration were used 
to screen and test for TB among general outpatients, PLWH, diabetics and contacts and yields 
compared (Ohene et al., 2017). In the first approach, the conventional 2 weeks cough 
duration with or without other TB suggestive symptoms was the criterion to test for TB. In 
the second approach the screening criteria were cough of >24 hours, as well as a history of at 
least one of the following symptoms: fever, weight loss and drenching night sweats. In the 
second approach using >24-hour cough, significantly more presumptive TB cases were 
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identified among outpatients (0.82% versus 0.63%), more were tested (90.1% versus 86.7%), 
but less smear positive patients were identified among those tested (8.0% versus 9.4%). 
Overall, all forms of TB cases identified per 100,000 screened were significantly higher in 
the >24-hour cough approach.  This approach yielded more TB cases although it required TB 
testing for a larger number of patients. The yield of TB cases per 100,000 population 
screened was highest among PLWH, TB contacts, and diabetics.  The findings of this study 
suggest that more sensitive methods of  screening based on risk factors is effective in 
increasing TB case finding. 
2.5.2 Missed opportunities in facility based TB screening 
In South Africa, patients have access to free TB diagnostic services through a wide network 
of public primary health care facilities. Based on estimates derived from national electronic 
TB register data and laboratory data, testing was not accessed in only 5% of the estimated 
number of TB cases (Naidoo et al., 2017).  However, in spite of widespread access to TB 
testing and care, empirical evidence from recent studies in South Africa suggests that there 
are still numerous missed opportunities at PHC facilities to test patients for TB (Table 4).  
Several explanations have been offered for missed opportunities to diagnose TB amongst 
patients seeking health care, and include amongst others; poor access to primary health care; 
delays in providing a diagnosis once the patient presents at a health service and the 
availability of appropriate tests and treatment (Davis et al., 2011). The results below are from 
high TB and HIV prevalence settings and underscore the missed opportunities to diagnose 
active TB disease among people who are seek health care.  
Table 4 Results from facility level studies on missed opportunities to diagnose TB amongst 
patients seeking care in South Africa 
Author, year Population Participants 
n 
TB Screen + 
n 
TB + 
n 
Claassens, 2013 PHC clinics 665 423 (63.6%) 21 (4.9%) 
Chihota, 2015 PHC clinics 3,604 2,130 (59.1%) ND 
Kweza, 2018 PHC clinics 1,255 779 (62.0) 39 (5.0%) 
2.5.2.1 Identifying those that do not report TB symptoms as their primary complaint 
In Cape Town, Claassens et al. (2013) conducted exit interviews at two PHC facilities and 
found only 3.8% of participants who exited the health facility had been questioned by HCWs 
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about respiratory symptoms.  Of those exiting, 5% had culture positive TB, all of whom were 
symptomatic, had not been screened, and had attended the facility for other reasons and had 
not reported respiratory symptoms to HCWs. The findings suggest incorporating TB 
screening into routine health activities at intake could avert missed opportunities to diagnose 
active TB disease.   
2.5.2.2 Delays in providing a diagnosis and appropriate testing once patients present at 
a health service 
Chihota et al. (2015) conducted exit interviews amongst adults with respiratory symptoms at 
40 clinics in four provinces. The purpose was to determine amongst the adults who reported 
TB symptoms to HCWs, the proportion that had a sputum test and the factors associated with 
having a sputum test.    Just under one-third (31.6%) of participants reported the main reason 
for visiting the clinic was for TB symptoms. Of those that had reported their TB symptoms to 
a HCW, 77% were not tested for TB.  The findings of this study suggest that opportunities 
are being missed to identify patients with active TB disease where patients present with 
symptoms suggestive of TB at a health care facility.  
The findings of a study by Kweza et al. (2018) were similar to those of Chihota suggesting 
that opportunities are missed to identify patients with active TB disease where patients 
present with symptoms suggestive of TB. TB symptomatic individuals exiting 20 PHC 
facilities in Buffalo City Metropolitan Health District were interviewed and asked to provide 
sputum for testing. Clinic staff had screened 79% of participants seeking care for TB related 
symptoms; however only 21.5% reported submitting sputum and only 9.8% had results 
available. Of the participants not tested by clinic staff, 5% tested positive for TB.  
These studies did not delve into reasons for the missed opportunities to identify patients with 
active TB disease, be they staffing shortfalls, inadequate provider education, a scarcity of 
testing supplies, lack of guiding policies, or other reasons.  
2.5.2.3 Poor health seeking behaviour of patients with respiratory symptoms 
Early diagnosis and immediate initiation of treatment are essential for an effective TB control 
programme. Delay in diagnosis is significant to both disease prognosis at the individual level 
and transmission within the community.  
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According to findings by Skinner et al. (2016) many adult patients waited for advanced 
symptoms to appear, and were very ill or even dysfunctional when they finally presented at 
health care facilities, often with smear-positive disease. Asch et al. (1998) found patients 
delayed in seeking care as they thought they could treat themselves, or were disconnected 
from the health care system by unemployment or lack of access to regular health care. The 
findings were similar to a study in Pakistan, where more than 50% of patients practiced self-
treatment, and 42% first visited their pharmacy for medication for symptoms (WHO, 2006).  
Storla et al. (2008) conducted a systematic review of studies addressing delay in diagnosis 
and treatment of TB. Factors were associated with both patient and health system delays. 
Main factors associated with patient delay included  alcohol or substance abuse, poverty, low 
access to health care facilities, rural residence, old age, belonging to an indigenous group and 
incomprehensive attitudes, beliefs and knowledge about TB.  Factors associated with health 
care delay included co-existence of chronic cough and/or other lung diseases, having extra 
pulmonary or negative sputum smear TB, less severe and non-specific symptoms or absence 
of haemoptysis, poor health care infrastructure and seeking traditional and private 
practitioners first.  
Kerrigan, et.al (2017) conducted a qualitative study to inform the development of active case 
finding strategies, where semi-structured in-depth interviews were conducted among TB 
patients, their household members and HCWs in a rural province in South Africa. TB patients 
and community members reported difficulty identifying TB symptoms and seeking care in a 
timely fashion. All stakeholder groups felt that more proactive case finding strategies would 
be beneficial. Incorporating TB screening into routine health activities at intake at PHC 
facilities was identified as the most acceptable method based on participants’ preference 
ranking of the active case finding strategies.  
Findings from these studies suggest that systematic TB screening in PHC facilities and 
appropriate testing should not be limited to patients who report respiratory symptoms or those 
who are HIV positive.  Given the high prevalence of TB in South Africa, incorporating TB 
screening into routine health activities at intake could avert missed opportunities to diagnose 
active TB disease. 
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2.5.3 Initial lost to follow-up after facility-based TB screening and testing 
Patients with a laboratory confirmed diagnosis of TB and who never start anti-TB treatment 
are classified as initial lost to follow-up (ILTFU). Pre-treatment ILTFU can hinder TB 
control efforts as individuals who test positive for active TB but do not initiate treatment 
contribute to on-going transmission within communities. In the analysis undertaken by 
Naidoo et al. (2017) of the TB care cascade in South Africa, where the number and 
proportion of individuals with TB who accessed tests, were diagnosed with TB, initiated 
treatment, and successfully completed treatment were estimated. It was found an estimated 
12% of all cases were diagnosed but not notified and treated.  
MacPherson et al. (2013) conducted a systematic review and meta-analysis to assess the 
magnitude of ILTFU in TB patients before treatment initiation. From the eligible studies pre-
treatment ILTFU rates varied from 4 to 38%.  
Khan et al. (2009) reported 5.2% of smear positive patients identified through active case 
finding strategies were ILTFU during diagnosis and therefore could not be started on 
treatment. At a regional hospital in Ghana, of the laboratory confirmed cases 38% were 
ILTFU (Afutu, 2012). Similar rates of initial ILTFU, 21.6% were found at a referral hospital 
in northern India (Mehra et al., 2013). Cele et al. (2016) measured initial TB ILTFU in PHC 
clinics in a district with a high incidence of TB in South Africa and reported initial ILTFU 
rates of 17.9% and of those traced, 53% had already died.  
Skinner et al. (2016) reported the key issues contributing to ILTFU to be a combination of 
poor knowledge, or low awareness of TB treatment; stigma around TB including its 
connection to HIV; immediate problems in the respondents’ lives particularly poverty, lack of 
access to transport and the need to continue working; and problems in the healthcare facilities 
including under resourced facilities, poor functioning health systems and negative staff 
attitudes. 
The high level of ILTFU in TB is one of the “unresolved issues” in TB control programmes 
that needs to be addressed. These findings suggest that unless health systems are responsive 
to retain and commence presumptive TB patients on treatment once they have been screened 
and tested, screening efforts may have little impact.  
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2.5.4 Quality of TB diagnostic evaluation in PHC facilities 
TB screening is inappropriate unless diagnostic and treatment services of sufficient quality 
are available. Studies of the quality of TB diagnostic evaluation of patients in high burden 
countries have generally shown poor adherence to international or national guidelines. 
Naidoo, et al. (2017) reported that poor compliance with the diagnostic algorithm have major 
implications for case detection and reported that if algorithms were adhered to it would 
reduce the number of TB cases missed by almost 32,000.  
Cattamanchi et al. (2011) conducted structured in-depth interviews with staff working in 
health centres in Uganda to elicit their perceptions regarding barriers to TB screening and 
diagnosis. Participants identified key health system barriers hindering TB screening and 
diagnosis and included amongst others, inadequate space and infrastructure, lack of training, 
high workload and low staff motivation. Contextual barrier challenges to TB diagnosis 
including the time and costs borne by patients to seek and complete TB screening and testing, 
poor health literacy, and stigma against patients with TB. These contextual barriers interacted 
with health system barriers to contribute to sub-standard TB screening and diagnosis. 
Christian et al. (2018) suggest that increasing healthcare coverage is unlikely to improve 
health outcomes if the quality of care and protocol implementation is lagging. This multi-
district Standardised (mystery) Patient (SP) study was conducted at 39 PHC facilities in two 
provinces in South Africa to objectively measure the quality of TB screening at PHC 
facilities using the SP method. The methodology applied allowed researchers to observe how 
HCWs identify, test and advise presumptive TB patients, and whether this aligned with 
clinical protocols and best practice. It was found that only 43% of interactions resulted in SPs 
receiving a TB sputum test and being offered an HIV test; just over half were asked whether 
household contacts had confirmed TB and only 28% received an explanation on the 
importance of returning to the facility to receive TB test results. The SP method highlighted 
gaps in clinical practice, gaps and weaknesses in TB protocol implementation signalling 
missed opportunities for diagnosis.  
2.6 Conclusion 
The studies suggest that there are many missed opportunities to screen for TB. However for 
such opportunities to result in increased TB case-findings, symptom screening needs to be 
actively followed up with sputum testing and improved adherence to clinical protocols.   
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The findings of these studies support conducting further operational research to assess 
whether the change in the TB screening strategy in City Health PHC facilities in Cape Town 
has translated into identifying and testing more presumptive TB cases and starting those who 
test positive on TB treatment.  
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Chapter 3: Aims and Objectives 
3.1 Study Aim 
The aim of this study was to evaluate the effects of an intensified TB screening strategy on 
changes in facility level TB case finding in City Health fixed PHC facilities in Cape Town. 
3.2 Study Objectives  
The objectives of this study were: 
1. To compare the proportion of all patients five years and older i) screened positive for 
TB symptoms, ii) investigated, iii) diagnosed and iv) commenced on TB therapy in 
PHC facilities in 2015 and 2017, before and after the implementation of the 
intensified TB screening strategy; 
2. To determine whether there was an association of a diagnosis of active TB identified 
through the intensified TB screening strategy with age, having a history of previous 
TB, gender, HIV status and year of diagnosis. 
3. If case finding following intensified screening is increased, to quantify how many 
patients need to be screened for TB in PHC facilities to detect one case with active TB 
disease; 
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Chapter 4: Research Methodology 
4.1 Study Design 
The study design was a before and after study of changes in facility level TB case finding 
following implementation of  an intensified TB screening strategy, by comparing data on 
patients screened and tested from the same facilities in 2015 and 2017. As the strategy was 
implemented in all facilities simultaneously, there were no control groups. 
4.2 Study Population  
The study population consisted of all patients five years and older seeking care at 82 City 
Health PHC facilities in Cape Town who were screened for active TB and registered in 
PREHMIS TB Identification Register for the period 2015 and 2017.   
4.3 Sampling 
No sampling was conducted and all the surveillance data on the system was used.  
4.4 Data Collection 
Data in PREHMIS are derived from patient information which are collected and recorded in 
standard PHC facility patient folders. Data fields in the electronic TB Identification Register 
are standardised and data elements are captured in the same sequence for each patient. This 
register allows for real time reporting of all presumptive TB cases and the outcomes of the 
sputum tests.  
Data on PHC headcount five years and older and presumptive TB patients (from the 
electronic TB Identification register) were extracted from the back end of the PREHMIS 
electronic database per facility and per month for the period January to December in 2015 
and 2017 in excel spread sheet formats.  Individual patient information extracted from the TB 
Identification register included laboratory tested for TB, laboratory diagnosed for TB, 
commencement on TB treatment and age, gender, HIV status, and history of previous TB. 
Names were removed from the individual patient entries. Facility-level aggregated data by 
year were extracted for PHC headcount and number of patients screened for TB symptoms.  
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4.5 Pre-Analysis Data Cleaning 
Extensive pre-analysis data cleaning was done.  Data were imported from the PREHIMS (csv 
file format) into an Access database to identify potential duplicate records.  Queries were 
performed to identify duplicate records using patient number, date of birth and gender and 
further refined using intake date and days between encounters. True duplicates were 
identified as matching on the above criteria and having intake dates of between 0-29 days 
apart. Using these criteria, 5,531 potential duplicates were identified out of a total of 104,354 
records.  The data were then exported back into Excel, and duplicates checked against facility 
name, laboratory results and care status. If there was evidence of a TB test result and patient 
was linked to care, the second record was deleted. A total of 2,703 duplicate records were 
deleted from the database.  A further 1,348 records from PHC facilities who did not report 
data for both time periods of analysis were deleted. Finally, the 1,430 records of children 
under 5 years were removed.. A total of 98,873 records were thus available for analysis 
(Figure 2).  
Figure 2 Data cleaning flow chart 
 
 
 
 
 
The following data inaccuracies were identified and corrections made: 
• 22 records with no gender assigned were changed to unknown 
• 12,464 in which HIV status was not specified were changed to HIV status unknown 
• 73 records where patient category was not assigned were changed to unknown 
• 73 records which did not have TB laboratory results were changed to unknown  
All Records 
n= 104,354 
True duplicates 
n= 2,703 
 
Not reporting facilities 
n = 1,348 
Children < 5 years 
n= 1,430 
 
Records Analysed 
n= 98,873 
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In order to conduct the analysis by sub-district, a column was added to the database  and all 
PHC facilities were linked to a specific sub-district.  
4.6 Analysis 
The statistical analysis was conducted using STATA (version 14.2, StataCorp LP, College 
Station, Texas). Statistical support was provided by a qualified epidemiologist. 
Descriptive analyses was done to compare baseline characteristics of the two patient cohorts. 
These were summarised as proportions for categorical variables, and medians with 
interquartile ranges (IQRs) for continuous variables. The indicators were analysed by year for 
2015 and 2017. A chi square test was applied to test for differences in ratios and rates over 
the two time periods, per PHC facility and sub-district. 
The total number and proportions were used to demonstrate the cascade of testing and 
treatment initiation using a simple flow diagram to demonstrate the proportion of PHC 
Headcount 5 years and older i) screened for TB symptoms, ii) screened positive for TB 
symptoms, iii) investigated, iv) diagnosed and v) commenced on TB therapy in PHC 
facilities.  
Scatterplots were used to describe the correlation between case detection rates and percentage 
patients screened by facility for each period using Spearmans correlation coefficient. 
Univariate and multivariate analysis was performed to determine associations between 
individual patient characteristics (age, having a history of previous TB, gender, HIV status, 
year of diagnosis). Odds ratios and 95% confidence intervals were calculated. Significance 
testing was performed using two sided P-values of <0.05. Forward selection methods were 
used to build the multivariate models and the log likelihood ratio test was used to compare 
nested models. The most appropriate model was chosen based on the log likelihood ratio test 
with the highest Chi squared value and a P-value < 0.05. The Akaikes Information Criterion 
(AIC) was used to compare non-nested models with the best model having the lowest AIC. 
The Pearson goodness-of-fit test was used to assess the overall fit of the models, with a P-
value < 0.05 indicating good fit. Model diagnostics was performed to check the form of the 
linear predictor, the adequacy of the link function and identify any outlying or influential 
observations.  
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4.7 Indicators  
The following outcome and process indicators were measured in each facility in 2015 and 
again in 2017.  
4.7.1 Outcome Indicator 
Indicator Numerator Denominator 
Clients 5 years and older per 
1000 PHC headcount initiated 
on TB treatment 
Number clients  5 years and 
older initiated  on TB treatment  
Number PHC headcount 5 
years and older 
4.7.2 Process Indicators 
Indicator Numerator Denominator 
% PHC Headcount 5 years and 
older screened for TB 
Number  clients 5 years and 
older screened for TB 
symptoms 
Number  PHC headcount 5 
years and older 
% PHC Headcount 5 years and 
older screened  positive for TB 
symptoms 
Number  clients 5 years and 
older identified with TB 
symptoms 
Number  clients 5 years and 
older screened for TB 
symptoms 
%  Client 5 years and older  
with TB symptoms laboratory 
tested for TB 
Number  clients 5 years and 
older  with TB symptoms 
laboratory tested for TB 
Number  clients 5 years and 
older identified with TB 
symptoms 
% Client 5 years and older  
with laboratory diagnosed TB 
Number  clients 5 years and 
older  with laboratory 
diagnosed TB 
Number clients 5 years and 
older  with TB symptoms 
laboratory tested for TB 
% Client 5 years and older  
diagnosed initiated on TB  
treatment 
Number clients 5 years and 
older  diagnosed initiated on 
TB  treatment 
Number  clients 5 years and 
older  with laboratory 
diagnosed TB 
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4.8 Validity  
Measurement bias could have occurred as all the data fields in the electronic TB 
Identification Registers were not completed. This however was minimal and here were no 
notable differences in the completion rates in 2015 compared to 2017. These data are also 
regularly captured and updated for reports that are required at a city, provincial and national 
level thus indicative that the data needs to be verified, accurate and more complete. 
All patients were screened using the standard WHO four-symptom TB questionnaire namely 
cough ≥ 2 weeks, fever, weight loss, and night sweats (WHO, 2011). All sputum tests were 
conducted at one regional laboratory that has strict internal quality assurance procedures to 
ensure uniformity and standardization. The laboratory follows a standardised testing 
algorithm; therefore all patients would have had the same probability of the same tests being 
conducted on samples submitted.  
4.9 Reliability 
Data fields in the presumptive TB register were standardised and data was captured in the 
same sequence and ordered manner for each client. 
4.10 Generalizability 
It is assumed that the adults attending facilities in 2015 and 2017 are representative of the 
population seeking care at City Health PHC facilities and the patient profile was similar those 
seeking care at MDHS facilities.  
It was anticipated that the findings would have broader relevance as this research study could 
be generalised to other populations or groups in different PHC settings with a similar disease 
burden where patients are screened and tested for TB. 
4.11 Limitations of Study 
A limitation was that the existing variables in PREHMIS were pre-determined, and the 
researcher had minimal control on additional variables, such as reason for visit to PHC 
facility that could have added value to this study. A possible further limitation was that 
routine programmatic data was used which was not collected specifically for this study, thus 
certain variables may have been unavailable and data quality poor. Absence of control groups 
was a further limitation of this study. Changes in TB case finding could have been due to 
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background secular trends, for example in patient demand for testing or the result of other 
interventions.   
4.12 Ethical Considerations 
The data used in this analysis was routine data collected by the City Health. Data was 
extracted from PREHMIS.  City Health are the custodians of patients accessing their services, 
hence prior to the extraction of the data and data analysis, permission was sought from City 
Health to use the data (Appendix 2).   
This was a retrospective review of routine data and it was not feasible to retrace all 
individuals and obtain permission for the collection of the routine data. No personal 
identifiers were included in the data sets used for analysis and reporting. An application for a 
waiver of informed consent was sought from the UWC Biomedical Research Ethics 
Committee.  Access to data was limited and every effort was made to protect the 
confidentiality of individual data. The data file was password protected and was stored on an 
external hard drive.  
Ethics approval for this project was obtained from the UWC Biomedical Research Ethics 
Committee (Appendix 3). At the conclusion of this study, City Health will be provided with a 
full report on study findings. 
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Chapter 5: Results 
5.1 Introduction 
Data were extracted from PREHMIS for 82 primary health care facilities for the periods 2015 
and 2017. A total of 104,354 records were extracted of which 98,873 presumptive TB patient 
records (i.e. with positive TB symptom screen) were included in the analysis, 51,387 and 
47,486 in the 2015 and 2017 cohorts, respectively.  
5.2 TB Symptom Screen  
Figure 3 shows the headcounts ≥5 years and the numbers reportedly screened for TB 
symptoms in 2015 and 2017, respectively. There was an overall 1.7% decline in the PHC 
headcount ≥5 years from 1,927,431 in 2015 to 1,895,613 in 2017 (Figure 1). There was a 3.5 
fold increase in the  PHC headcount ≥5 years screened for TB symptoms increased from 
223,967 in 2015 to 801,873 in 2017 (11.6% versus 42.3%).  
 
Figure 3 PHC headcount≥ 5 years and number who were screened for TB symptoms in 2015 
and 2017 cohorts 
 
 
 
 
 
Of the patients who had a TB symptom screen performed, 22.9% screened positive for TB 
symptoms in 2015 compared to 5.9% in 2017 (Figure 4). In both years, a high proportion of 
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testing: 99.3% in 2015 and 95.4% in 2017.  Of all the presumptive TB patients who had 
sputum samples sent for testing in 2015, 7,625  had a positive sputum test for MTB on either 
Xpert MTB/RIF, TB smear or TB culture compared 6,924 in 2017 (14.9% versus 15.3%). 
Overall the number of patients with a positive sputum test declined by 9.2% over the two 
years. In 2015, 83.5% of the patients who had a sputum test positive for MTB were 
commenced on TB therapy, compared to 85.4% in 2017. Overall the number of patients 
initiated onto TB treatment declined by 7.2% over the two years. 
 
Figure 4 Proportion screened positive for TB symptoms, investigated, diagnosed positive and 
commenced on TB therapy 
 
 
 
 
5.3 Demographic Characteristics of Presumptive TB patients 
The baseline characteristics of the 2015 and 2017 presumptive TB case cohorts are compared 
in Table 5.  There was a 7.6% decline in numbers of recorded presumptive TB patients in the 
two years. However, the overall profile of presumptive patients remained the same. Just over 
half (51.3%) of presumptive TB patients were male in both cohorts.  HIV status was recorded 
for 94.2% of the patients, 23.3% of whom (n =23,103) were HIV positive.  The median age 
of presumptive TB patients was 36 years (IQR 25-47).   History of previous TB episodes was 
recorded for 96.2% of patients, 79.9% of whom (n= 79,014) had no history of a previous TB 
treatment episode.   
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Table 5 A comparison of baseline characteristics of presumptive TB patients in 2015 and 2017 
  2015 cohort 
n (%) 
2017 cohort 
n (%) 
All patients 51,387 (51.9) 47,486 (48.0) 
Sex   
Male 26,379 (51.3) 24,383 (51.3) 
Female 25,004 (48.6) 23,086 (48.6) 
HIV status   
HIV-positive 12,418 (24.1) 10,685 (22.5) 
HIV-negative 36,090 (70.2) 34,059 (71.7) 
HIV status unknown 2,879 (5.6) 2,742 (5.7) 
Age, years, median (IQR) 36 (25-46) 36 (25-47) 
Patient Category   
Unknown 1,452 (2.8) 2,318 (4.8) 
New 42,118 (81.9) 36,896 (77.7) 
Retreatment 7,726 (15.0) 8,185 (17.2) 
Drug Resistant Contact  91 (0.1) 87 (0.1) 
 
The presumptive TB patients spanned the entire age range. Figure 5 shows a comparison of 
the age categories and sex of presumptive TB patients in the 2015 and 2017 cohorts. The 
majority (79.2%) of all the presumptive TB patients were aged between 15 and 54 years (n= 
78,326). A 2.8% decline was observed in these age categories between 2015 and 2017. The 
largest declines were in males and females aged 25- 34 years, with declines of 13.1% and 
11.2% respectively. There was simultaneously a 10.2% increase in those 55 years and older. 
Eight percent (n= 8,246) of presumptive TB patients were aged between 5 and 14 years 
where a 13.7% increase was observed between 2015 and 2017.  
 
Figure 5  Percentage age-sex distribution of presumptive TB patients in 2015 and 2017 
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A higher proportion of women in age categories 15-24 years and 25-34 years were HIV 
positive compared to males, equalising from 35 years onwards (Figure 6).   
 
Figure 6  HIV positive status by age and sex of presumptive TB patients in 2015 and 2017 
 
 
 
5.3.1 Demographic characteristics of presumptive TB patients by sub-district 
There were similarities in the proportion of presumptive TB patients by sex across the sub-
districts (Table 6). The most notable increase was observed in Klipfontein sub-district where 
there was a 36.7% increase in males in 2017 compared to 2015. The proportion of males 
versus females was significantly different (p=<0.001). 
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Table 6 A comparison of sex of presumptive TB patients in 2015 and 2017 by sub-district 
 
  2015 cohort n (%) 
P  
value 
2017 cohort 
n (%) 
P  
value 
Sub-District Male Female Unknown 
<0.001 
Male Female Unknown 
<0.001 
Eastern 3,879 (51.7) 
3,628 
(48.3) 0 
3,604 
(51.9) 
3,330 
(48.0) 2 (0.03) 
Khayelitsha 1,705 (53.7) 
1,466 
(46.2) 0 
2,591 
(53.0) 
2,291 
(46.9) 1 (0.02) 
Klipfontein 2,592 (54.0) 
2,202 
(45.9) 0 
2,760 
(55.4) 
2,225 
(44.6) 1 (0.02) 
Mitchells 
Plain 
4,014 
(50.3) 
3,969 
(49.7) 0 
3,544 
(50.5) 
3,467 
(49.4) 2 (0.03) 
Northern 3,565 (50.5) 
3,488 
(49.4) 2 (0.03) 
2,261 
(50.7) 
2,192 
(49.1) 3 (0.07) 
Southern 2,204 (52.3) 
2,006 
(47.6) 0 
2,050 
(52..3) 
1,864 
(47.6) 1 (0.03) 
Tygerberg 6,432 (49.5) 
6,555 
(50.4) 2 (0.02) 
6,000 
(48.6) 
6,322 
(51.2) 6 (0.05) 
Western 1,988 (54.0) 
1,690 
(46.0) 0 
1,573 
(53.0) 
1,395 
(47.0) 1 (0.03) 
         
 
There were significant variations in the proportion of presumptive TB patients who were HIV 
positive across the sub-districts (Table 7). Almost half of the presumptive TB patients in 
Khayelitsha were HIV positive compared to Tygerberg sub-district where only 13% were 
HIV positive. A 61.4% increase in HIV positive presumptive TB patients was observed in 
Khayelitsha sub-district between 2015 and 2017, In all other sub-districts declines in the 
percentage of HIV positive presumptive TB patients was observed, most notably a decline of 
52.4% was noted in Northern sub-district. The proportion of HIV positive versus HIV 
negative patients was significantly different (p=<0.001). 
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Table 7 A comparison of HIV status of presumptive TB patients in 2015 and 2017 by sub-
district 
  2015 cohort 
n (%) 
P 
value 
2017 cohort 
n (%) 
P value 
Sub-
District HIV+ve HIV-ve Unknown  
HIV+ve HIV-ve Unknown 
 
Eastern 2,038 
(27.2) 
5,239 
(69.8) 
230 
(3.0) 
<0.001 
1,627 
(23.5) 
5,034 
(72.6) 
275 
(3.9) 
<0.001 
Khayelitsha 1,511 
(47.7) 
1,546 
(48.7) 
114 
(3.6) 
2,438 
(49.9) 
2,277 
(46.6) 
168 
(3.4) 
Klipfontein 853 
(17.8) 
3,556 
(74.2) 
385 
(8.0) 
872 
(17.5) 
3,634 
(72.9) 
480 
(9.6) 
Mitchells 
Plain 
1,509 
(18.9) 
6,094 
(76.3) 
380 
(4.8) 
1,307 
(18.6) 
5,363 
(76.5) 
343 
(4.9) 
Northern 2,722 
(38.6) 
3,885 
(55.1) 
448 
(6.3) 
1,296 
(29.1) 
2,876 
(64.5) 
284 
(6.4) 
Southern 999 
(23.7) 
3,069 
(72.9) 
142 
(3.4) 
813 
(20.8) 
2,962 
(75.7) 
140 
(3.5) 
Tygerberg 1,763 
(13.6) 
10,256 
(78.9) 
970 
(7.5) 
1,619 
(13.1) 
9,974 
(80.9) 
735 
(6.0) 
Western 1,023 
(27.8) 
2,445 
(66.5) 
210 
(5.7) 
713 
(24.0) 
1,939 
(65.3) 
317 
(10.7) 
                  
There were variations in the proportion of presumptive TB patients who had a recorded 
history of previous TB treatment episodes across the sub-districts (Table 8) comparing 2015 
to 2017. Increases were observed in Khayelitsha (140.5%), Klipfontein (6.7%), Southern 
(29.4%) and Tygerberg (32.3%). The proportion of new versus retreatment patients was 
significantly different (p=<0.001). 
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Table 8 A comparison of patient category of presumptive TB patients in 2015 and 2017 by sub-district 
  2015 cohort n (%) P value 2017 
n (%) 
P value 
Sub-District Unknown New  ReRx DR-TB contact 
<0.001 
Unknown New  ReRx DR-TB contact 
<0.001 
Eastern 83 (1.1) 5,929 (79.0) 1,480 (19.7) 15 (0.2) 300 (4.3) 5,310 (76.5) 1,322 (19.0) 4 (0.1) 
Khayelitsha 25 (0.8) 2,623 (82.7) 511 (16.1) 12 (0.4) 326 (6.7) 3,314 (67.8) 1,229 (25.1) 14 (0.3) 
Klipfontein 23 (0.5) 3,873 (51.2) 896 (18.7) 2 (0.04) 335(6.7) 3,692 (74.0) 956 (19.1) 3 (0.1) 
Mitchells Plain 443 (5.5) 6,268 (78.5) 1,259 (15.7) 13 (0.2) 309 (4.4) 5,559 (79.2) 1,140 (16.3) 5 (0.1) 
Northern 142 (2.0) 5,629 (79.8) 1,265 (18.0) 19 (0.2) 212 (4.7) 3,490 (78.3) 751 (16.8) 3 (0.1) 
Southern 217 (5.1) 3,738 (89.0) 252 (6.0) 3 (0.1) 105 (2.7) 3,472 (88.7) 326 (8.3) 12 (0.3) 
Tygerberg 439 (3.4) 10,883 (83.8) 1,644 (12.6) 23 (0.2) 558 (4.5) 9,553 (77.5) 2,175 (17.6) 42 (0.4) 
Western 80 (2.2) 3,175 (86.3) 419 (11.4) 4 (0.1) 173 (5.8) 2,506 (84.4) 286 (9.6) 4 (0.1) 
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5.4 Positive test for Mycobacterium Tuberculosis 
Positive MTB test results by test type are shown in Table 9. Of the 14,549 presumptive TB 
patients who tested positive for MTB in the two years, 88.3% (n=12,848) had a positive 
sputum test for MTB on Xpert MTB/RIF, of whom 3.4% (n=488)   tested MTB/RIF resistant. 
 
Table 9 Proportion of presumptive TB patients ≥5 years who were sputum test positive by test 
type in 2015 and 2017 
  
2015 cohort 
n (%) 
2017 cohort 
n (%) 
Tested positive for TB 7,625 6,924 
Xpert MTB/RIF sensitive 6,386 (83,7) 5,917 (85.5) 
Xpert MTB/RIF inconclusive 37 (0,5) 20 (0.3) 
Xpert MTB/RIF resistant 279 (3,7) 209 (3.0) 
TB smear positive 372 (4,9) 331 (4.8) 
TB culture positive 551 (7,2) 447 (6,5) 
 
Positive MTB test results are shown in Table 10. Just under two thirds of presumptive TB 
patients who tested positive for MTB were male (60.8%).  Between 2015 and 2017 the 
proportion of males and females was not significantly different (p=0.132). The HIV 
prevalence of TB patients was 33.9%.  Between 2015 and 2017 the proportion of HIV 
positive and HIV negative was significantly different (p=<0.001). The majority (55.1%) who 
tested positive for MTB were in the age group 25- 44 years (n= 8,037). There was an 11.9% 
increase in patients who have a recorded history of previous TB treatment episodes. Between 
2015 and 2017 the proportion of new and retreatment patients was significantly different (p= 
<0.001). A 11.7% decline was noted amongst females and a 12.4% decline in age groups 15-
34 years between 2015 and 2017; these are consistent with declines reported in patients aged 
25- 34 years (Figure 5). Between 2015 and 2017 the proportion of patients by age category 
was not significantly different (p=<0.092). There was a 14.7% decline in HIV positive 
patients between 2015 and 2017 and this reflects the higher proportion of women in age 
categories 15-34 years were HIV positive compared to males (Figure 6).  
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Table 10 Percentage presumptive TB patients tested positive for TB by sex, HIV status, patient 
category and age category in 2015 and 2017 
  
2015 cohort 
n (%) 
2017 cohort 
n (%) P value 
Sex    
Male 4,601 (60.3) 4,253 (61.4) 
0,132* Female 3,024 (39.6) 2,669 (38.5) 
HIV status    
HIV-positive 2,662 (34.9) 2,271 (32.8) 
<0.001* HIV-negative 4,639 (60.8) 4,285 (61.8) 
HIV status unknown 324 (4.2) 368 (5.3) 
Patient Category    
Unknown 158 (2.0) 53 (0.7) 
<0.001* 
New 5,966 78.2) 5,203 (75.1) 
Retreatment 1,475 (19.3) 1,651 (23.8) 
Drug Resistant 
Contact  26 (0.3) 17 (0.2) 
Age Categories    
5-9 years 28 (0.3) 28 (0.4) 
0,092* 
10-14 years 97 (1.2) 98 (1.4) 
15-24 years 1,480 (19.4) 1,263 (18.2) 
25-34 years 2,385 (31.2) 2,122 (30.6) 
35-44 years 1,826 (23.9) 1,704 (24.6) 
45-54 years 1,218 (15.9) 1,089 (15.7) 
≥55 years 591 (7.7) 620 (8.9) 
* chi squared: difference between 2015 and 2017 by sex, HIV status, patient category and age categories 
 
5.5 Presumptive TB patients tested positive for TB commenced on TB treatment 
Of the presumptive TB patients who tested positive for TB, 84.4% (n= 12,283) commenced 
TB treatment with 15.3% (n=2,224) lost to follow-up (Table 11). Between 2015 and 2017 the 
proportion of patients LTFU, died and on TB treatment was significantly different (p=0.007)  
 
Table 11 Percentage presumptive TB patients tested positive for TB by care status in 2015 and 
2017 
  
2015 cohort 
n (%) 
2017 cohort 
n (%) P value 
LTFU 1,234 (16.1) 990 (14.3) 
0.007 Died 21 (0.28) 21 (0.30) 
On TB Rx 6,370 (83.5) 5,913 (85.4) 
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Table 12 shows the rates of lost to follow-up between males and females, there was no 
significant difference in the rates of lost to follow-up when comparing females to males in 
2015 (p=0.731) and 2017 (p=0.962).  
 
Table 12 Percentage presumptive TB patients tested positive for TB lost to follow-up by sex in 
2015 and 2017 
  2015 n (%) 
P 
value 
2017 
n (%) 
P 
value 
 LTF Died On TB Rx 
 LTF Died On TB Rx  
Male 749 
(16,28) 
11 
(0,24) 
3,841 
(83,48) 0.731* 
601 
(14,13) 
13 
(0,31) 
3,639 
(85,56) 0.962* Female 485 
(16,04) 
10 
(0,33) 
2,529 
(83,63) 
389 
(14,57) 
8 
 (0,30) 
2,272 
(85,13) 
* chi squared: difference between sexes           
 
5.6 Case Detection Rates  
In 2015, one patient with active TB disease was detected for every 29 patients screened. In 
2017, one active TB patient was detected for every 116 patients screened.  Despite the 
increased screening, the case detection rate per 1,000 PHC headcount ≥5 years declined 
slightly from 4.0 in 2015 to 3.7 in 2017.  
There were wide disparities in case detection rates between the health sub-districts in 2015 
(Table 13) compared to 2017 (Table 14).  Khayelitsha had the highest number of patients 
testing positive for TB in both 2015 and 2017 however had the lowest case detection rates.  
Northern sub-district had a similar number of patients testing positive for TB compared to 
Khayelitsha, however had the highest case detection rates overall.  
Overall all sub-districts increased the PHC headcount ≥5 years screened for TB in 2017 
compared to 2015; however all sub-districts reported a decline in the number of patients 
screened positive for TB symptoms in 2017 compared to 2015, with the exception of 
Khayelitsha and Klipfontein who reported 54% and 4% increases respectively. All sub-
districts reported declines in those tested positive in 2017 compared to 2015, with the 
exception of Khayelitsha and Klipfontein who reported 63.1% and 12.3% increases 
respectively.   
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Western sub-district and Northern sub-district had to screen 7.6 and 6.2 times more patients 
to detect one patient with active TB disease in 2017 compared 2015, where Khayelitsha sub-
district only had to screen 1.4 times more patients to detect one patient with active TB 
disease. Similarly, all sub-districts reported declines in case detection rates in 2017 compared 
to 2015, with the exception of Khayelitsha and Klipfontein who reported 0.9% and 1% 
increases respectively.  
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Table 13 Screening, testing and TB case detection rate per 1,000 PHC headcount ≥5 years by health sub-district in 2015 
  2015 
  
PHC 
headcount 
≥ 5 years 
Screen for TB 
symptoms ≥5 years  
Screened +ve for TB 
symptoms Investigated for TB Tested +ve for TB 
Commenced on TB 
therapy 
Case 
detection 
rate 
Eastern 258 528 30 129 11,7% 7 507 24,9% 7 462 99,4% 1 214 16,3% 1 082 87,5% 4,7 
Khayelitsha 330 087 34 310 10,4% 3 171 9,2% 3 153 99,4% 575 18,2% 457 76,5% 1,7 
Klipfontein 188 954 29 467 15,6% 4 794 16,3% 4 772 99,5% 734 15,4% 605 80,9% 3,9 
Mitchells Plain 325 308 38 226 11,8% 7 983 20,9% 7 924 99,3% 1 206 15,2% 1 023 83,5% 3,7 
Northern 169 265 19 463 11,5% 7 055 36,2% 6 990 99,1% 1 094 15,7% 905 80,1% 6,5 
Southern 210 818 24 376 11,6% 4 210 17,3% 4 180 99,3% 657 15,7% 545 82,5% 3,1 
Tygerberg 246 422 32 890 13,3% 12 989 39,5% 12 896 99,3% 1 518 11,8% 1 173 75,8% 6,2 
Western 198 049 15 106 7,6% 3 678 24,3% 3 669 99,8% 627 17,1% 580 92,7% 3,2 
 
Table 14 Screening, testing and TB case detection per 1,000 PHC headcount ≥5 years by sub-district in 2017 
  2017 
  
PHC 
headcount 
≥ 5 years 
Screen for TB 
symptoms ≥5 years  
Screened +ve for TB 
symptoms Investigated for TB Tested +ve for TB 
Commenced on TB 
therapy 
Case 
detection 
rate 
Eastern 247 721 107 037 43,2% 6 936 6,5% 6 688 96,4% 1 016 15,2% 901 89,0% 4,1 
Khayelitsha 361 585 77 259 21,4% 4 883 6,3% 4 588 94,0% 938 20,4% 655 69,6% 2,6 
Klipfontein 169 007 87 030 51,5% 4 986 5,7% 4 658 93,4% 824 17,7% 714 87,4% 4,9 
Mitchells Plain 314 058 126 039 40,1% 7 013 5,6% 6 701 95,6% 1 034 15,4% 935 91,0% 3,3 
Northern 164 127 93 699 57,1% 4 456 4,8% 4 265 95,7% 852 20,0% 767 92,0% 5,2 
Southern 197 206 110 300 55,9% 3 915 3,5% 3 807 97,2% 517 13,6% 463 90,3% 2,6 
Tygerberg 254 579 116 110 45,6% 12 328 10,6% 11 797 95,7% 1 284 10,9% 1067 84,2% 5,0 
Western 187 330 84 399 45,1% 2 969 3,5% 2 821 95,0% 459 16,3% 411 90,0% 2,5 
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The scatterplot (Figure 7) shows the correlation between percentage PHC headcount ≥5 years 
screened for TB symptoms and case detection rate per 1,000 PHC headcount in 82 PHC 
facilities in 2015 and 2017 (Appendix 4). There was no significant linear association between 
percentage screened for TB symptoms and case detection rate in 2015 (r=0.064; p=0.568) or 
in 2017 (r=-0.124; p=0.268). In 2015 screening levels ranged from 3% to 36% with case 
detection rates ranging from 0.3 to 17, with most screening clustered at less than 20% and 
case detection rates less than 8.  In 2017 screening levels ranged from 14% to 92% with case 
detection rates ranging from 0.4 to 15, with most screening clustered between 40% to 60% 
and case detection rates remaining at less than 8.   
 
Figure 7 Correlation between % PHC headcount ≥5 years screened for TB symptoms and case 
detection rate per 1,000 PHC headcount in 2015 and 2017 
 
 
 
 
 
5.7 Multivariate analysis of factors associated with a diagnosis of active TB  
Multivariate logistical regression analysis was done to determine if there was an association 
of a diagnosis of active TB identified with individual patient variables (sex, HIV status, age, 
history of previous TB and year of diagnosis), sub-district as a group level variable, and year 
of screening. Results of univariable and multivariable analyses are shown in Table 15.  
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Table 15 Univariable and multivariable analyses of factors associated with a diagnosis of active 
TB 
  Univariable    Multivariable 
Characteristic OR (95%CI)  P value    aOR (95%CI)  P value 
Sex      
Male 1,55 (1.49 - 1.61) <0.001  1.59 (1.53 - 1.65) <0.001 
Female 1    1  
Unknown 0.79 (0.18 - 3.42) 0.755  1.00 (0.22 - 4.43) 0.990 
HIV status        
HIV-positive 1.94 (1.87 - 2.02) <0.001  1.65 (1.58 - 1.72) <0.001 
HIV-negative 1    1  
HIV status unknown 0.99 (0.91 - 1.08) 0.958  0.98 (0.90 - 1.07) 0.002 
Age Categories        
5-9 years 0.06 (0.46 - 0.79) <0.001  0.76 (0.58 - 0.99) <0.001 
10-14 years 0.23 (0.20 - 0.27) <0.001  0.28 (0.24- 0.33) <0.001 
15-24 years 0.95 (0.90 - 1.00) 0.094  1.10 (1.04 - 1.16) <0.001 
25-34 years 1    1  
35-44 years 0.93 (0.88 - 0.98) 0.006  0.85 (0.81 - 0.90) <0.001 
45-54 years 0.74 (0.70 - 0.79) <0.001  0.75 (0.71 - 0.79) <0.001 
≥55 years 0.49 (0.46 - 0.52) <0.001  0.54 (0.50 - 0.58) <0.001 
Patient Category        
Unknown 1.08 (0.93 - 1.25) 0.295  0.99 (0.85 - 1.16) 0.999 
New 1    1  
Retreatment 1.49 (1.42 - 1.55) <0.001  1.30 (1.24 - 1.36) <0.001 
Drug Resistant 
Contact  2.12 (1.49 - 3.02) <0.001 
 1.97 (1.38 - 2.83) <0.001 
Year        
2015 1    1  
2017 1.02 (0.98 - 1.05) 0.262  1.03 (0.99 - 1.07) 0.063 
Sub-District        
Eastern 1.38 (1.30 - 1.46) <0.001  1.24 (1.16 - 1.32) 0.001 
Khayelitsha 2.14 (1.99 - 2.29) <0.001  1.62 (1.50 - 1.74) <0.001 
Klipfontein 1.52 (1.42 - 1.62)  <0.001  1.44 (1.34 - 1.54) <0.001 
Mitchells Plain 1.38 (1.30 -1.46) <0.001  1.32 (1.24 - 1.40) <0.001 
Northern 1.60 (1.50 - 1.70) <0.001  1.37 (1.28 - 1.46) <0.001 
Southern 1.29 (1.20 -1.39) <0.001  1.23 (1.14 - 1.32) <0.001 
Tygerberg 1    1  
Western 1.52 (1.41 - 1.64) <0.001   1.37 (1.27 - 1.48) 0.049 
 
Being male, HIV positive, history of previous TB treatment episodes and being a contact of a 
known drug resistant TB index case were all associated with a diagnosis of active TB disease 
on univariate and multivariate analysis. 
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The probability of a diagnosis of active TB was similar in age category 15-24 years and 25-
34 years.  Presumptive TB patients in age category 10-14 years (aOR 0.28 , 95% CI, 0.24- 
0.33, p=<0.001)were the least likely to have a diagnosis of active TB disease as compared to 
the age  category 25-34 years.   
Presumptive TB patients with a history of previous treatment episodes were 30% (95% CI, 
1.24 - 1.36, p=<0.001) more likely to have a diagnosis of active TB disease compared to 
presumptive TB patients who have never had a previous TB treatment episode. Presumptive 
TB patients who had contact with a confirmed drug resistant index patient were 97% (95% 
CI, 1.38 - 2.83, p=<0.001) more likely to have a diagnosis of active TB disease compared to 
presumptive TB patients who have never had a previous TB treatment. 
There was no difference in the likelihood of a diagnosis of active TB disease when 
comparing by year of diagnosis (aOR 1.03, 95% CI, 0.99 – 1.07, p= 0.063).  
In the multivariate analysis the likelihood of presumptive TB patients having a diagnosis of 
active TB was similar across sub-districts, with the exception of  Khayelitsha Sub-District 
where it was 62% (95% CI, (1.50 – 21.74, p=<0.001) more likely compared to Tygerberg 
Sub-District.  
 
  
http://etd.uwc.ac.za/
2721605 Page 41 
 
Chapter 6: Discussion  
6.1 Discussion 
The purpose of this study was to evaluate if the strategy implemented by City Health to 
systematically screen all people who seek health care at PHC facilities, regardless of their 
risk profile or reasons for presenting to health services, for active TB disease has translated 
into increased TB testing, diagnosis and treatment of undiagnosed incident cases and averted 
missed opportunities to diagnose TB. The study assessed changes from 2015 to 2017 of a 
large sample in a real world setting in the context of a service provision profile consisting of 
mainly HIV and TB treatment and other preventive health services.  
6.1.1 Case Detection  
Despite, very big increases in reported screening rates, from 11.6% to 42.3%, presumptive 
cases identified and overall case detection in fact decreased over the period (the latter from 
4.0 per 1,000 PHC headcount ≥ 5 years in 2015 to 3.7 in 2017).  The data from individual 
facilities and sub-districts showed variable uptake rates but no consistent pattern (up or 
down) of presumptive or confirmed cases with increased screening. Although not statistically 
significant, increased screening rates appeared to be associated with decreased levels of case 
detection. 
As levels of case detection remained similar, a possible interpretation could be that as overall 
incidence of TB is declining in Cape Town; the screening has played a role in maintaining 
case detection rates. Hermans et al. (2015) reported that in Cape Town as ART coverage 
increased TB notification rates and TB incidence declined and that decreases were highest in 
HIV positive populations.  A possible further explanation could be that protocols and 
procedures have been implemented to systematically screen PLWH for active TB at each 
visit to a PHC facility and that there is limited additional value of screening all other patients 
attending PHC services for other preventive services.  
None of the studies reviewed reported case detection per 1,000 PHC headcount, but rather as 
a proportion of those screened for TB symptoms. In Botswana (Bloss, et al., 2012) and 
Johannesburg (Van Rie, et al., 2014) reported a 0.2% and a 0.4% case detection rate of all 
patients screened whilst this study found  a case detection rate of 1.4% amongst patients 
screened. 
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In good screening programmes, about 10% of sputum samples collected from presumptive 
TB patients should be sputum-confirmed. Rates of bacteriologically confirmed TB were 
14.9% in 2015 and 15.3% in 2017. These were much higher compared to recent studies 
conducted in Swaziland (Uplekar et al., 2013), Botswana (Bloss, et al., 2012) and 
Johannesburg (Van Rie, et.al, 2014) which reported rates of 8.4%, 2.1% and 8% of 
bacteriologically confirmed TB respectively.  
There were variable rates of bacteriologically confirmed TB between the sub-districts, 
ranging from 18.8% in Khayelitsha to 11.1% in Tygerberg. The multivariable logistic 
regression analysis showed that the odds of having a diagnosis of active TB disease was 1.94 
fold higher amongst presumptive TB patients in Khayelitsha. Of interest is that in Northern 
sub-district the rates of bacteriologically confirmed TB (16.9%) were similar to those of 
Khayelitsha, however the case detection rate was 5.8 per 1,000 PHC headcount ≥ 5 years 
compared to only 2.1 in Khayelitsha. This could reflect different patient profiles and public 
sector utilisation patterns, or alternatively, insufficient screening in Khayelitsha, a sub-district 
profiled by high rates of HIV and TB prevalence as well as the added burden of high levels of 
social deprivation.  
In South Africa, all PHC clinic attendees are required to have a TB symptom screen at entry. 
However, it is possible that large scale symptom screening in PHC clinics may negatively 
impact the quality of symptom screening that takes place. Massyn et al. (2017) reported that 
in 2016/17 nationally the TB symptom ≥5 years screened in facility rate was 51.6%. 
However, there was no evidence that this resulted in an increase in the identification of cases 
with active TB disease. As with the City Health PHC facilities, in the absence of a 
counterfactual (controls) it is uncertain if case detection rates would have declined even 
further should the “universal” screening strategy have not been implemented.  
Another possible explanation is that “universal” screening independent of symptomatology of 
all people seeking health care at PHC facilities has diluted the effect of prior screening 
strategies.  Several studies have reported low sensitivity to the four question TB screening 
tool recommended by WHO. Claassens et al. (2017) reported that results from the 
ZAMSTAR study found that the sensitivity of using only cough >2 weeks as a screening rule 
was less than 25% in both SA and Zambia. Studies have suggested that many TB patients 
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who are minimally symptomatic symptom-driven TB screening may be an insufficient case 
finding tool (Van Schalkwyk, et al., 2018).   
6.1.2 Factors associated with a diagnosis of active TB 
Being male, HIV positive, history of previous TB treatment episodes and being a contact of a 
known drug resistant TB index case were all associated with a diagnosis of active TB disease 
on univariate and multivariate analysis. 
6.1.2.1 Sex 
Gender differentials in TB have been reported worldwide. WHO Global Report (2017) 
estimated that globally men accounted for 65% of incident cases of TB. In this study just over 
half (51.3%) of presumptive TB patients were male in both cohorts. The multivariable 
logistic regression analysis showed that the odds of having a diagnosis of active TB disease 
was 1.59 fold higher amongst males. This is similar to findings from a study conducted in 
South-Western Uganda, where it was reported that the TB prevalence was higher among 
males than females with presumptive TB and that the increased risk of TB among males was 
independent of other TB risk factors (Boum, et al., 2014).  These findings emphasize the need 
for gender focused interventions aimed at reducing TB transmission. 
6.1.2.2 HIV+ve 
International Standards for TB Care (2014) recommend that HIV testing should be done on 
all patients suspected of or with TB particularly in areas with high HIV prevalence as TB is 
an important gateway to HIV care and is a major presenting opportunistic infection in the 
majority of HIV positive patients with low CD4 counts.  In HIV positive patients ART 
reduces individual TB risk by two-thirds, however patients on ART remain at an advanced 
risk for recurrent TB due to partial immune restoration. 
The multivariable logistic regression analysis showed that the odds of having a diagnosis of 
active TB disease were 1.65 fold higher in HIV positive presumptive TB patients. There was 
a high uptake of HIV testing with 94.2% of the presumptive patients having HIV status 
recorded and of whom 23.3% were HIV positive. Results from two separate Indian studies 
reported much lower rates of known HIV status of 44.6% and 68% and of whom 3.3% and 
8% were HIV positive respectively (Palanivel, et al., 2013 & Kumar, et al., 2017).  
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It is unknown what proportion of the patients who were HIV positive were on ART and what 
proportion had HIV status confirmed by point of care testing at the time of being investigated 
for TB. Patients with HIV associated tuberculosis have asymptomatic disease or very minor 
symptoms and this could account for why the proportion of HIV positive presumptive TB 
patients is lower than reported in the TB treatment programme where it has been reported that 
just less than 50 % of patients on TB treatment in Cape Town are HIV positive (Hermans, et 
al., 2017). In the same study it was reported that 28% of HIV positive patients were 
commenced on TB treatment empirically, suggesting that potentially in large proportion of 
HIV positive patients a diagnosis of active TB disease is missed through routine TB symptom 
screening.  
6.1.2.3 Age  
Ages of presumptive TB clients spanned the entire range and were similar in both cohorts. 
The majority (79.2%) of all the presumptive TB patients were aged between 15 and 54 years, 
with only 8.2% of presumptive TB patients aged between 5 and 14 years and 12.4%  being 
≥55 years.  In the regression analysis the probability of a diagnosis of active TB was similar 
in age categories 15-24 years and 25-34 years. 
A significantly higher proportion of women in age categories 15-24 years and 25-34 years 
were HIV positive compared to males. This is consistent with age distribution reported by 
Statistics South Africa (2017) who reported that one-fifth of South African women in their 
reproductive ages (15-49 years) are HIV positive, with the prevalence highest among women 
aged 25-34 and women in the teenage population were eight times that of their male 
equivalents. 
6.1.2.4 Patient Category 
There is evidence from tuberculosis high-burden settings that exogenous reinfection 
contributes considerably to recurrent disease. Relapse occurred early after treatment 
completion, whereas reinfection dominated after one year and accounted for at least half of 
recurrent disease (Marx, et al., 2014). Hermans et al. (2017) reported in Cape Town rates of 
30% previously treated from TB treatment programme data. The multivariate regression 
analysis showed that the odds of having a diagnosis of active TB disease was 1.30 fold higher 
in TB presumptive patients with a history of previous TB treatment episodes. It was 
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surprising to note that only 16% of presumptive TB patients had a recorded history of a 
previous TB treatment episode. Similar rates of previous history of TB episodes were 
reported amongst presumptive TB patients testing positive in a study conducted by Kweza et 
al. (2018). A possible explanation could be poor history taking of previous TB treatment 
episodes amongst presumptive TB patients or failure of patients to disclose previous TB 
treatment episodes. 
The odds of having a diagnosis of active TB disease were 1.97 fold higher in presumptive TB 
who had a recorded history of contact with known drug resistant TB index case. Kweza et al. 
(2018) reported that amongst presumptive TB patients who tested positive 7.7% reported as 
having a current contact and 18% reported contact within the past year. In a recent study 
conducted it was found there was TB prevalence of 3.9% amongst close household contacts 
of recently diagnosed TB index patients.  This study reported that symptom screening among 
household contacts had low sensitivity and specificity for active TB (Little et al., 2018). Data 
from a study in Brazil suggested that the prevalence of tuberculous infection and progression 
to active TB among household contacts exposed to drug sensitive and drug resistant cases 
were comparable, despite a longer duration of exposure of contacts to drug resistant TB index 
cases (Teixeira et al., 2001). Close contacts of known TB index patients are a specific high 
risk group and consideration could be given to exploring alternative methods of screening 
this group.  
6.1.2.5 Investigated for TB 
Naidoo et al (2017) estimated that about 13% of all cases were lost between TB testing and 
diagnosis and asserted that this was partly due to failure to comply with diagnostic 
algorithms. Results from a study conducted by Kweza et al. (2018) in Eastern Cape reported 
that about half of the study participants visited the clinics because of their TB symptoms; 
80% of them reported that they were screened for TB in the clinic, but only 18% submitted a 
sputum sample to the clinic staff. 
The findings from this study found that patients with a positive TB symptom screen were 
highly likely (97.5%) to have sputum samples obtained and sent for testing and only 5% of 
those tested did not have a test result recorded. Of the outstanding results, it is unknown what 
proportion of these outstanding results tested positive or whether results were indeed obtained 
and acted on by clinicians. In this study it is unknown how many patients who had a positive 
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TB symptom screen in PHC facilities were not recorded in the TB identification register and 
thus not tested and it could be speculated that rates of lost to follow up between a positive 
screening test and testing is much higher. 
In South Africa, sputum smear microscopy has been replaced with Xpert MTB/RIF as the 
initial diagnostic test for TB in people who report at least one positive TB symptom on the 
WHO screening tool. A further observation by Naidoo et al. (2017) found that in South 
Africa <60% of presumptive TB patients received an Xpert MTB/RIF test and the remainder 
were tested with less sensitive smear microscopy. Churchyard et al. (2015) compared the 
effect Xpert MTB/RIF with fluorescence microscopy and noted a 50% higher rate of 
presumptive TB patients with bacteriological confirmation of TB in the Xpert MTB/RIF 
group. 
There was exceptional adherence to testing algorithms with 88% of presumptive TB patients 
receiving an Xpert MTB/RIF test; the remaining 11.7% were tested by smear microscopy 
and/or TB culture. The local diagnostic algorithm applied in this setting advocates that 
patients with a recent history of TB disease (≤ 2 years) should not have a diagnostic TB test 
using Xpert MTB/RIF as there is a likelihood of a false positive test result and should be 
tested by smear microscopy and culture. The local diagnostic algorithm not to use Xpert 
MTB/RIF test in patients with a history of a recent previous TB treatment episode is 
supported by findings from a study conducted by Theron et al. (2018) which found the 
specificity of Xpert MTB/RIF to be lower in patients with a recent history of previous TB.  A 
limitation of this study was that although history of previous TB episodes was recorded, it 
was not recorded how recent this previous episode was and thus explain why there was not a 
greater concordance with the local diagnostic algorithm. 
6.1.2.6 Initial Lost to Follow Up 
An initial lost to follow up (ILTFU) is someone who has been diagnosed with sputum-
confirmed PTB, but has no record of having started treatment so remains an infection risk for 
others (Harries, et al., 2009). Pre-treatment ILTFU can hinder TB control efforts and is a 
concern for TB programmes globally as the TB burden will not be reduced if patients 
diagnosed with TB are not started on treatment.  Rapid case identification of individuals with 
sputum positive TB and rapid initiation of anti-tuberculosis chemotherapy are key to 
controlling TB. 
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In a systematic review and meta-analysis conducted by MacPherson et al. (2013) it was 
reported pre-treatment ILTFU rates from the various studies varied from 4.0% to 38.0% and 
was common in studies from Africa. Naidoo et al. (2017) estimated in TB care cascade in 
South Africa that 12.0% of patients did not initiate treatment. This study found the pre-
treatment ILTFU rates were similar in both cohorts with 15.3% of presumptive TB patients 
ILTFU. There is no significant difference in the rates of lost to follow-up when comparing 
females (15.4%) to males (15.3%).The frequency of ILTFU was not uniform in all sub-
districts with 8.2% in the Western sub-district and 26.4% in Khayelitsha sub-district. These 
findings are similar to a study conducted by Cele et al. (2016) conducted in KwaZulu Natal 
which found ILTFU occurred in 17.9 % of PTB cases and that there was no significant 
difference males and females and the frequency of ILTFU was not uniform in all sub-districts 
It reported that of the 16.0% of ILTFU who were traced, 53% had died before 
commencement of TB treatment. High rates of ILTFU (38%) were reported from a study in 
Ghana where sputum positive TB patients, diagnosed in the laboratory were never start anti-
TB treatment (Afutu, et al., (2012). 
Reductions in pre-treatment ILTFU have the potential to be a potent intervention and are 
more easily achievable within the current health infrastructure than active case finding.  
6.2 Limitations  
A limitation of the study was that routine programmatic data were used which were not 
collected specifically for this study, thus certain variables were unavailable; the existing 
variables in PREHMIS were pre-determined, and the researcher had no control on collection 
of additional variables. This study therefore was unable to measure and assess several factors 
that could have impacted on the effectiveness of screening such as reason for visit to PHC 
facility, and which presumptive TB patients were identified through passive case finding and 
those identified through active case finding. Although history of previous TB episodes was 
recorded, it was not specified how recent this previous episode was to explain why there was 
not a greater concordance with the local diagnostic algorithm. 
Despite processes having been implemented to improve data collection, missing data was still 
found in the electronic database and database had missing data points, for different variables 
between patients.  
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There was a possible over estimation of the PHC headcount ≥ 5 years as headcount data 
included patient visits for those patients on TB treatment. 
Initial lost to follow up were not traced to determine outcome, neither were these patients 
cross checked with names in TB treatment registers to ascertain if treatment was initiated.  
This was a before and after study with no controls and the absence of control groups is a 
further limitation of this study. Changes in TB case finding may have been due to background 
secular trends. The data from the electronic presumptive TB registers is limited to the 
participants attending City Health PHC facilities; hence the findings did not extend to 
presumptive TB patients attending other public PHC facilities and those attending private 
facilities.  
It is possible that the implementation of this strategy needs longer than one year to show a 
significant effect on improved case detection and should be re-evaluated once screening 
practices are further entrenched in routine health activities at PHC facilities.  
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Chapter 7: Conclusion and Recommendations 
7.1 Conclusion 
The importance of activities geared toward the detection and treatment of TB early within the 
disease process cannot be overstated. The symptomatic period, from the first appearance of 
TB symptoms to treatment initiation, presents huge challenges to health systems, particularly 
in early stages of disease where patients are minimally symptomatic. Improving TB case 
detection together with earlier treatment initiation should contribute to reducing TB 
transmission. However, the key finding from this study is that current strategies of 
“universal” screening have not shown to be effective in this context. Despite very big 
increases in reported screening rates, presumptive cases identified and overall case detection 
in fact decreased over the period. The data from individual facilities and sub-districts showed 
variable uptake rates but no consistent pattern (up or down) of presumptive or confirmed 
cases with increased screening, if anything increased screening rates were associated with 
decreased levels of case detection. Other strategies of “universal testing” would need to be 
considered and further research conducted.  
A positive finding from this study was that patients with a positive TB symptom screen were 
highly likely to have sputum samples obtained and sent for testing and there was exceptional 
adherence to testing algorithms.  
Another important finding was high rates of ILTFU were reported. Reductions in ILTFU 
have the potential to be a potent intervention and are more easily achievable within the 
current health infrastructure than active case finding.  
7.2 Recommendations 
• It is recommended City Health re-evaluate the current policy and implementation 
practices of “universal” screening of all people who seek health care at PHC facilities, 
regardless of their risk profile or reasons for presenting to health services.  
 
• A recommendation could be to implement “universal testing” irrespective of 
symptoms for high risk groups identified in this study, i.e. HIV positive, history of 
previous TB treatment episodes and being a contact of a known TB index case. 
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However this will need to be evidenced by further research on yield, affordability and 
cost effectiveness. 
 
• Another recommendation would be to consider broadening the criteria for a positive 
screen to include other key clinical and demographic characteristics in the screening 
tool, for instance body mass index and smoking history. This could possibly improve 
sensitivity to symptom screening alone, followed by the current diagnostic algorithm. 
 
• It is recommended local health managers identify facilities with poor screening and 
those where symptomatic patients are not being tested for TB to improve screening 
and testing at these facilities. 
 
• High rates of ILTFU need to be further investigated and strategies implemented to 
reduce these rates. 
 
• In an effort to find the “missing cases”, it is recommended consideration be given to 
making greater use of lay persons and CHWs to conduct and assist with active TB 
case-finding within their respective communities especially in tracing and screening 
household contacts of known TB index cases.  
 
• The proportion of incomplete records needs further auditing and consideration given 
to strategies to improve data capturing. Data capturing could be improved by the 
direct import of laboratory results into the database and thus improve the number of 
results not available.  
 
• It is recommended that consideration be given to improving the efficiency and 
effectiveness of the current electronic database by designing electronic gate keeping 
rules to eliminate unnecessary repeat testing. 
 
. 
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Appendix 1: Implementation guidelines for TB screening  
 
STANDARD OPERATING PROCEDURE FOR TB SCREENING IN ALL PHC HEALTH 
FACILITIES 
TITLE TB Screening   
DATE: 12 May 2016 (amended 26 September 2016) 
BACKGROUND: 
 
The South African National Department of Health (NDoH) adopted the WHO and STOP TB Partnership 90 90 
90 strategy in March 2015 that will move South Africa towards achieving the 90-90-90 targets for HIV and TB 
by 2020. The targets for TB are that: 
1. 90% of vulnerable groups screened for TB 
2. 90% of those diagnosed with TB are treated 
3. 90% treatment success rate 
People with undiagnosed, untreated and potentially infectious TB are frequently seen in PHC facilities. There 
are many missed opportunities to screen clients for TB symptoms at each clinical visit. Clients with 
undiagnosed infectious TB pose a risk of nosocomial transmission in PHC facilities and transmission in 
communities. 
 
This SOP thus serves as a guideline to facilitate implementation of routine TB screening in all PHC health 
facilities  
1. All clients 5 years and older entering a PHC facility must be screened for TB 
2. All clients 5 years and older entering a PHC facility must be asked to disclosure coughing status as 
they enter the facility  
3. All clients identified with a cough should be fast tracked through the reception  area to be 
screened for TB and those screened positive must be investigated further 
4. The TB sticker can  be used as supporting evidence of TB screening in individual client clinic folders 
5. TB screening (including that done in  settings in which it is recorded on standardised stationery or 
in clinical notes) must be recorded and reported on the routine monthly report (RMR tick sheet) 
6. All clients using the facility must be encouraged to wear a paper mask for the duration they are in 
the facility 
Responsibility for communicating 
SOP to all PHC staff and monitoring 
implementation  
• Facility managers 
• Facility operational managers  
• HAST Managers  
• HAST Co-ordinators  
• Primary Health Care Managers 
References and source material 
• PACK- Screen client in the preparation room ( page 3 – PACK 
guideline 2016) 
• PIDS ( TB definitions) 
Tools, material & equipment 
• TB Screening Sticker 
• Standardised stationery and/or clinical notes 
• Routine monthly data sheet  (RMR) 
• TB suspect sputum register (MDHS) 
• Prehmis (City PHC facilities) 
• NHLS: Trakcare 
Purpose of indicator • To monitor if  all  PHC facility attendees  5 years and older are 
screened for TB  
Definition: numerator 
 
 
 
• All clients 5 years and older attending PHC health facilities 
who are screened for TB symptoms 
• Count the number of clients who respond (positive and 
negative) to  TB symptom screening questions  
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Denominator 
 
• PHC headcount 5 years and older 
Absolute Validation Rule • All clients 5 years and older attending health facilities who 
were screened for TB symptoms (positive and negative) 
should be equal to or less than PHC head count 5 years and 
older. 
 
 
PROCEDURE Responsible person 
Cough Hygiene 
• All clients entering the facility should be encouraged to wear paper masks for the 
duration they are in the facility irrespective if they are coughing  and reason for 
visiting the health facility 
• Display various posters in prominent positons in the waiting area in reception and 
other high volume waiting areas encouraging clients to disclosure coughing status 
and promoting cough hygiene  
• Erect mask dispensers with paper masks in  prominent positions and  ensure these 
are readily available to all clients as they enter the facility in reception and all other 
high volume waiting areas together with tissues  
• Daily health education sessions on cough hygiene should be conducted in 
reception areas  
• All coughing clients should be informed that TB is spread by coughing and in their 
own interests and those of their fellow clients and staff, be requested to cough into 
tissues or their elbow, and not their hand or into the air 
• Reception 
staff 
 
 
 
 
 
 
 
• Identified PHC 
facility TB 
champion 
and/or health 
promoters 
TB Screening 
• A staff member should be assigned the responsibility of encouraging all clients to 
disclosure coughing status as they enter the facility – this is best done in the 
reception area 
• All clients identified with a cough should be fast tracked through the reception  
area to be screened for TB 
• All clients if screened positive must be investigated further and 2 sputum samples 
must  be taken and sent for  TB testing 
• All clients >5 years must be screened for TB with each and EVERY clinical visit  - see 
PACK 2016 guidelines page 3 
• Where and if possible, separate coughing clients from the general waiting area to 
a designated, well-ventilated sub-waiting area 
• Professional 
Clinical Staff 
Clinical Consulting Rooms equipped for TB Screening 
• Each clinical consulting room must be equipped with the following: 
o TB screening stickers 
o TB screening sheets for those who screen positive (history sheets) 
o NHLS sputum request forms 
o Sputum bottles 
o Plastic bags for sputum bottles 
•  
Client Screening Positive for TB Symptoms 
• If a client is screened positive ( as recorded on  TB screening sticker or in other 
stationery): 
o It is incumbent on the clinician treating the client to obtain sputum samples 
and not refer the client to another section of the facility for sputum collection 
o Obtain a detailed history from the client and record on TB Screening Tool 
o Label 2 sputum jars, explain sputum collection procedure to the client and 
request client to produce sputum  sample in external sputum booth 
o Request the client to wait 1 hour before producing second sputum sample 
o Request the client to return to clinical consulting room with both sputum 
samples 
o Ensure the client is given a 48 hour TCA date to come back to receive results 
o Clinician to ensure sputum samples are placed in plastic bags together with 
• Professional, 
clinical staff 
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completed sputum request forms 
o Patient folder and sputum samples to be delivered to procedure room and/or 
TB room for capture into the TB suspect register and manage according to the 
TB protocol 
Recording TB Screening 
• Stationery with TB Screening prompts (HCT & ART) 
o The standardised HCT and ART stationery have TB screening prompts – there is  
no need to ADD TB screening sticker 
o Tick screening in the appropriate section of the stationery 
o Record on RMR tick sheet  
§ MDHS: Client 5 years and older screened for TB symptoms 
§ City: Client screened negative/positive for TB symptoms 
§ In City facilities PHC folder to flow to reception for clerk to capture TB 
screening data in Prehmis 
• Stationery with NO TB Screening prompts 
o TB Screening sticker should be placed in PHC clinical records  
o Tick appropriate blocks according to response from client 
o Record on RMR tick sheet  
§ MDHS: Client 5 years and older screened for TB symptoms 
§ City: Client screened negative/positive for TB symptoms 
§ In City facilities PHC folder to flow to reception for clerk to capture TB 
screening in Prehmis 
• TB Screening Sheet (patient who self- presents with TB symptoms for investigation) 
o Complete TB screening sheet and place in PHC folder 
o Record on RMR tick sheet  
§ MDHS: Client 5 years and older screened positive for TB symptoms 
§ City: Client screened positive for TB symptoms 
§ Both MHDS and City:  TB suspect and no. sputum samples sent 
§ In City facilities PHC folder to flow to reception for clerk to capture TB 
screened positive, TB suspect category and no. sputums sent in Prehmis 
• Professional, 
clinical staff 
Stock TB Screening Stickers 
• Sub-district HAST co-ordinators and  sub-structure HAST clinical co-ordinators will 
provide each PHC facility  with stock 
• Please place order with the relevant sub-district and/or sub-structure co-ordinator 
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Appendix 4: Proportion of PHC headcount ≥5 years screened for TB symptoms, screened positive for TB symptoms, 
investigated, diagnosed positive and commenced on TB therapy in 82 PHC facilities 
 
  
2015 cohort  
n (%)     
 
PHC 
headcount 
≥ 5 years 
Screen for TB 
symptoms ≥5 
years  
Screened +ve for 
TB symptoms 
Investigated for 
TB 
Tested +ve for 
TB 
Commenced on 
TB therapy 
Case 
detection 
Started 
Rx 
Blue Downs Clinic 14 018 455 3,2% 956 210,1% 948 99,2% 98 10,3% 80 81,6% 7,0 5,7 
Dr Ivan Toms CDC 47 645 5 110 10,7% 1 004 19,6% 992 98,8% 171 17,2% 127 74,3% 3,6 2,7 
Eerste River Clinic 25 906 2 797 10,8% 1 197 42,8% 1 196 99,9% 168 14,0% 161 95,8% 6,5 6,2 
Gordon's Bay CDC 13 512 2 469 18,3% 326 13,2% 323 99,1% 39 12,1% 28 71,8% 2,9 2,1 
Ikhwezi CDC 82 793 7 562 9,1% 1 097 14,5% 1 087 99,1% 294 27,0% 269 91,5% 3,6 3,2 
Kuilsriver Clinic 7 272 1 803 24,8% 229 12,7% 229 100,0% 12 5,2% 9 75,0% 1,7 1,2 
Sarepta Clinic 15 420 2 288 14,8% 836 36,5% 835 99,9% 145 17,4% 135 93,1% 9,4 8,8 
Sir Lowry's Pass CDC 18 978 2 148 11,3% 311 14,5% 309 99,4% 56 18,1% 52 92,9% 3,0 2,7 
Somerset West Clinic 10 637 2 929 27,5% 228 7,8% 227 99,6% 52 22,9% 45 86,5% 4,9 4,2 
Wesbank Clinic 22 347 2 568 11,5% 1 323 51,5% 1 316 99,5% 179 13,6% 156 87,2% 8,0 7,0 
Eastern 258 528 30 129 11,7% 7 507 24,9% 7 462 99,4% 1 214 16,3% 1 062 87,5% 4,7 4,1 
Kuyasa CDC 55 165 6 473 11,7% 635 9,8% 631 99,4% 152 24,1% 121 79,6% 2,8 2,2 
Luvuyo CDC 39 725 6 263 15,8% 390 6,2% 390 100,0% 26 6,7% 14 53,8% 0,7 0,4 
Matthew Goniwe CDC 74 856 4 712 6,3% 719 15,3% 717 99,7% 124 17,3% 98 79,0% 1,7 1,3 
Mayenzeke Clinic 18 720 3 146 16,8% 232 7,4% 229 98,7% 43 18,8% 36 83,7% 2,3 1,9 
Nolungile Clinic 37 994 0 0,0% 16 #DIV/0! 12 75,0% 10 83,3% 227 2270,0% 0,3 6,0 
Site B Youth Clinic 20 294 4 716 23,2% 91 1,9% 91 100,0% 18 19,8% 14 77,8% 0,9 0,7 
Town 2 CDC 64 712 6 722 10,4% 905 13,5% 1188 131,3% 146 12,3% 119 81,5% 2,3 1,8 
Zakhele Clinic 18 621 2 278 12,2% 182 8,0% 180 98,9% 56 31,1% 34 60,7% 3,0 1,8 
Khayelitsha 330 087 34 310 10,4% 3 171 9,2% 3153 99,4% 575 18,2% 440 76,5% 1,7 1,3 
Guguletu Clinic 28 821 5 227 18,1% 1 313 25,1% 1 307 99,5% 169 12,9% 122 72,2% 5,9 4,2 
Hanover Park Clinic 12 951 1 950 15,1% 562 28,8% 561 99,8% 70 12,5% 63 90,0% 5,4 4,9 
Heideveld Clinic 11 104 3 412 30,7% 239 7,0% 238 99,6% 44 18,5% 34 77,3% 4,0 3,1 
Lansdowne Clinic 8 402 2 565 30,5% 178 6,9% 177 99,4% 34 19,2% 29 85,3% 4,0 3,5 
Manenberg Clinic 18 823 3 450 18,3% 798 23,1% 794 99,5% 111 14,0% 96 86,5% 5,9 5,1 
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Masincedane Clinic 22 656 3 556 15,7% 332 9,3% 330 99,4% 69 20,9% 60 87,0% 3,0 2,6 
Nyanga Clinic 37 243 1 586 4,3% 350 22,1% 348 99,4% 92 26,4% 74 80,4% 2,5 2,0 
Silvertown Clinic 10 403 2 299 22,1% 449 19,5% 447 99,6% 45 10,1% 38 84,4% 4,3 3,7 
Vuyani Clinic 38 551 5 422 14,1% 573 10,6% 570 99,5% 100 17,5% 78 78,0% 2,6 2,0 
Klipfontein 188 954 29 467 15,6% 4 794 16,3% 4 772 99,5% 734 15,4% 594 80,9% 3,9 3,1 
Crossroads 1 Clinic 15 233 3 221 21,1% 388 12,0% 381 98,2% 83 21,8% 76 91,6% 5,4 5,0 
Eastridge Clinic 29 330 4 355 14,8% 920 21,1% 915 99,5% 139 15,2% 125 89,9% 4,7 4,3 
Lentegeur Clinic 29 254 3 924 13,4% 1 531 39,0% 1 527 99,7% 216 14,1% 148 68,5% 7,4 5,1 
Mzamomhle Clinic 63 868 5 037 7,9% 834 16,6% 823 98,7% 192 23,3% 164 85,4% 3,0 2,6 
Phumlani Clinic 30 711 3 180 10,4% 793 24,9% 781 98,5% 140 17,9% 107 76,4% 4,6 3,5 
Rocklands Clinic 13 634 3 649 26,8% 517 14,2% 515 99,6% 48 9,3% 42 87,5% 3,5 3,1 
Tafelsig CDC 72 879 5 384 7,4% 1 573 29,2% 1 562 99,3% 169 10,8% 155 91,7% 2,3 2,1 
Weltevreden Valley Clinic 58 280 6 604 11,3% 1 063 16,1% 1 056 99,3% 189 17,9% 162 85,7% 3,2 2,8 
Westridge Clinic 12 119 2 872 23,7% 364 12,7% 364 100,0% 30 8,2% 28 93,3% 2,5 2,3 
Mitchells Plain 325 308 38 226 11,8% 7 983 20,9% 7 924 99,3% 1 206 15,2% 1 007 83,5% 3,7 3,1 
Bloekombos Clinic 48 897 2 881 5,9% 1 134 39,4% 1 130 99,6% 207 18,3% 171 82,6% 4,2 3,5 
Brackenfell Clinic 8 494 1 771 20,9% 219 12,4% 215 98,2% 16 7,4% 10 62,5% 1,9 1,2 
Brighton Clinic 8 042 2 106 26,2% 179 8,5% 178 99,4% 28 15,7% 15 53,6% 3,5 1,9 
Durbanville Clinic 11 236 2 431 21,6% 1 370 56,4% 1 364 99,6% 135 9,9% 111 82,2% 12,0 9,9 
Fisantekraal Clinic 12 425 2 263 18,2% 607 26,8% 606 99,8% 80 13,2% 68 85,0% 6,4 5,5 
Harmonie Clinic 8 994 1 567 17,4% 449 28,7% 447 99,6% 46 10,3% 36 78,3% 5,1 4,0 
Northpine Clinic 5 430 1 046 19,3% 75 7,2% 75 100,0% 12 16,0% 11 91,7% 2,2 2,0 
Scottsdene Clinic 10 096 2 394 23,7% 1 284 53,6% 1 276 99,4% 173 13,6% 126 72,8% 17,1 12,5 
Wallacedene Clinic 55 651 3 004 5,4% 1 738 57,9% 1 699 97,8% 397 23,4% 328 82,6% 7,1 5,9 
Northern 169 265 19 463 11,5% 7 055 36,2% 6 990 99,1% 1 094 15,7% 876 80,1% 6,5 5,2 
Alphen Clinic 905 252 27,8% 39 15,5% 39 100,0% 5 12,8% 5 100,0% 5,5 5,5 
Claremont Clinic 7 823 1 648 21,1% 158 9,6% 155 98,1% 29 18,7% 26 89,7% 3,7 3,3 
Diep River Clinic 5 102 960 18,8% 88 9,2% 86 97,7% 19 22,1% 15 78,9% 3,7 2,9 
Fish Hoek Clinic 4 493 882 19,6% 23 2,6% 23 100,0% 3 13,0% 3 100,0% 0,7 0,7 
Hout Bay Main Road Clinic 26 975 1 216 4,5% 234 19,2% 234 100,0% 47 20,1% 36 76,6% 1,7 1,3 
Klip Road Clinic 11 498 1 263 11,0% 326 25,8% 326 100,0% 70 21,5% 66 94,3% 6,1 5,7 
Lavender Hill Clinic 12 741 1 314 10,3% 364 27,7% 362 99,5% 69 19,1% 60 87,0% 5,4 4,7 
Masiphumelele Clinic 34 590 3 010 8,7% 647 21,5% 638 98,6% 111 17,4% 89 80,2% 3,2 2,6 
Muizenberg Clinic 3 349 1 211 36,2% 39 3,2% 39 100,0% 2 5,1% 1 50,0% 0,6 0,3 
Ocean View CDC 39 857 1 978 5,0% 501 25,3% 497 99,2% 46 9,3% 42 91,3% 1,2 1,1 
Parkwood Clinic 10 159 1 178 11,6% 269 22,8% 266 98,9% 29 10,9% 26 89,7% 2,9 2,6 
Philippi Clinic 8 080 1 343 16,6% 181 13,5% 181 100,0% 43 23,8% 31 72,1% 5,3 3,8 
Seawind Clinic 22 231 4 376 19,7% 750 17,1% 746 99,5% 108 14,5% 76 70,4% 4,9 3,4 
Strandfontein Clinic 9 013 1 396 15,5% 287 20,6% 284 99,0% 31 10,9% 25 80,6% 3,4 2,8 
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Westlake Clinic 5 676 1 268 22,3% 156 12,3% 156 100,0% 16 10,3% 14 87,5% 2,8 2,5 
Wynberg Clinic 8 326 1 081 13,0% 148 13,7% 148 100,0% 29 19,6% 27 93,1% 3,5 3,2 
Southern 210 818 24 376 11,6% 4 210 17,3% 4 180 99,3% 657 15,7% 542 82,5% 3,1 2,6 
Adriaanse Clinic 18 708 2 381 12,7% 1 178 49,5% 1 171 99,4% 136 11,6% 119 87,5% 7,3 6,4 
Delft South Clinic 55 072 5 802 10,5% 2 230 38,4% 2 214 99,3% 282 12,7% 209 74,1% 5,1 3,8 
Dirkie Uys Clinic 17 587 4 798 27,3% 961 20,0% 953 99,2% 83 8,7% 60 72,3% 4,7 3,4 
Elsies River Clinic 18 208 2 350 12,9% 1 416 60,3% 1 406 99,3% 167 11,9% 113 67,7% 9,2 6,2 
Kasselsvlei Clinic 16 773 2 646 15,8% 1 515 57,3% 1 499 98,9% 176 11,7% 140 79,5% 10,5 8,3 
Netreg Clinic 12 843 2 076 16,2% 1 096 52,8% 1 093 99,7% 120 11,0% 85 70,8% 9,3 6,6 
Parow Clinic 14 990 2 079 13,9% 705 33,9% 702 99,6% 77 11,0% 59 76,6% 5,1 3,9 
Ravensmead Clinic 21 769 2 362 10,9% 1 373 58,1% 1 362 99,2% 147 10,8% 75 51,0% 6,8 3,4 
St Vincent (CCT) CDC 44 576 4 357 9,8% 1 179 27,1% 1 169 99,2% 175 15,0% 156 89,1% 3,9 3,5 
Uitsig Clinic 14 649 1 849 12,6% 661 35,7% 656 99,2% 81 12,3% 66 81,5% 5,5 4,5 
Valhalla Park Clinic 11 247 2 190 19,5% 675 30,8% 671 99,4% 74 11,0% 69 93,2% 6,6 6,1 
Tygerberg 246 422 32 890 13,3% 12 989 39,5% 12 896 99,3% 1 518 11,8% 1 151 75,8% 6,2 4,7 
Albow Gardens CDC 69 553 2 300 3,3% 1 123 48,8% 1 122 99,9% 166 14,8% 154 92,8% 2,4 2,2 
Chapel Street Clinic 16 338 1 195 7,3% 141 11,8% 141 100,0% 32 22,7% 30 93,8% 2,0 1,8 
Factreton Clinic 10 914 1 160 10,6% 219 18,9% 217 99,1% 34 15,7% 23 67,6% 3,1 2,1 
Langa Clinic 50 396 2 288 4,5% 986 43,1% 985 99,9% 170 17,3% 157 92,4% 3,4 3,1 
Maitland Clinic 7 512 1 371 18,3% 179 13,1% 179 100,0% 10 5,6% 8 80,0% 1,3 1,1 
Melkbosstrand Clinic 1 883 237 12,6% 52 21,9% 52 100,0% 11 21,2% 9 81,8% 5,8 4,8 
Protea Park Clinic 11 994 1 883 15,7% 424 22,5% 421 99,3% 106 25,2% 100 94,3% 8,8 8,3 
Saxon Sea Clinic 10 247 1 369 13,4% 362 26,4% 361 99,7% 63 17,5% 57 90,5% 6,1 5,6 
Spencer Road Clinic 13 666 2 122 15,5% 135 6,4% 134 99,3% 24 17,9% 23 95,8% 1,8 1,7 
Table View Clinic 5 546 1 181 21,3% 57 4,8% 57 100,0% 11 19,3% 10 90,9% 2,0 1,8 
Western 198 049 15 106 7,6% 3 678 24,3% 3 669 99,8% 627 17,1% 581 92,7% 3,2 2,9 
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2017 cohort  
n (%) 
  
  
PHC 
headcount 
≥ 5 years 
Screen for TB 
symptoms ≥5 years  
Screened +ve for 
TB symptoms 
Investigated for 
TB 
Tested +ve for 
TB 
Commenced on 
TB therapy Case detection 
Started 
Rx 
Blue Downs Clinic 14 896 8 185 54,9% 768 9,4% 731 95,2% 99 13,5% 76 76,8% 6,6 5,1 
Dr Ivan Toms CDC 51 643 21 960 42,5% 856 3,9% 847 98,9% 144 17,0% 131 91,0% 2,8 2,5 
Eerste River Clinic 24 028 14 857 61,8% 1 260 8,5% 1 172 93,0% 138 11,8% 133 96,4% 5,7 5,5 
Gordon's Bay CDC 8 194 6 079 74,2% 261 4,3% 243 93,1% 18 7,4% 5 27,8% 2,2 0,6 
Ikhwezi CDC 81 569 27 759 34,0% 1 210 4,4% 1 181 97,6% 208 17,6% 194 93,3% 2,5 2,4 
Kuilsriver Clinic 6 940 3 659 52,7% 167 4,6% 166 99,4% 21 12,7% 12 57,1% 3,0 1,7 
Sarepta Clinic 13 124 4 692 35,8% 710 15,1% 705 99,3% 128 18,2% 119 93,0% 9,8 9,1 
Sir Lowry's Pass CDC 16 505 7 919 48,0% 369 4,7% 359 97,3% 57 15,9% 51 89,5% 3,5 3,1 
Somerset West Clinic 10 713 7 159 66,8% 269 3,8% 219 81,4% 35 16,0% 18 51,4% 3,3 1,7 
Wesbank Clinic 20 109 4 768 23,7% 1 066 22,4% 1 065 99,9% 179 16,8% 165 92,2% 8,9 8,2 
Eastern 247 721 107 037 43,2% 6 936 6,5% 6 688 96,4% 1 016 15,2% 904 89,0% 4,1 3,6 
Kuyasa CDC 71 117 13 754 19,3% 606 4,4% 578 95,4% 143 24,7% 135 94,4% 2,0 1,9 
Luvuyo CDC 44 561 11 562 25,9% 499 4,3% 391 78,4% 61 15,6% 33 54,1% 1,4 0,7 
Matthew Goniwe CDC 78 486 11 217 14,3% 450 4,0% 402 89,3% 80 19,9% 38 47,5% 1,0 0,5 
Mayenzeke Clinic 20 082 5 784 28,8% 186 3,2% 182 97,8% 32 17,6% 25 78,1% 1,6 1,2 
Nolungile Clinic 35 199 8 432 24,0% 1 564 18,5% 1 555 99,4% 374 24,1% 227 60,7% 10,6 6,4 
Site B Youth Clinic 19 715 11 983 60,8% 77 0,6% 68 88,3% 20 29,4% 19 95,0% 1,0 1,0 
Town 2 CDC 73 081 10 568 14,5% 1 251 11,8% 1 188 95,0% 195 16,4% 162 83,1% 2,7 2,2 
Zakhele Clinic 19 344 3 959 20,5% 250 6,3% 224 89,6% 33 14,7% 14 42,4% 1,7 0,7 
Khayelitsha 361 585 77 259 21,4% 4 883 6,3% 4 588 94,0% 938 20,4% 653 69,6% 2,6 1,8 
Guguletu Clinic 31 852 21 755 68,3% 1 407 6,5% 1 357 96,4% 230 16,9% 195 84,8% 7,2 6,1 
Hanover Park Clinic 11 783 6 853 58,2% 619 9,0% 588 95,0% 65 11,1% 56 86,2% 5,5 4,8 
Heideveld Clinic 10 379 4 473 43,1% 216 4,8% 158 73,1% 39 24,7% 29 74,4% 3,8 2,8 
Lansdowne Clinic 6 338 3 363 53,1% 164 4,9% 147 89,6% 22 15,0% 18 81,8% 3,5 2,8 
Manenberg Clinic 14 308 7 207 50,4% 873 12,1% 828 94,8% 132 15,9% 119 90,2% 9,2 8,3 
Masincedane Clinic 19 653 7 448 37,9% 248 3,3% 232 93,5% 60 25,9% 52 86,7% 3,1 2,6 
Nyanga Clinic 33 332 16 764 50,3% 539 3,2% 511 94,8% 149 29,2% 137 91,9% 4,5 4,1 
Silvertown Clinic 8 234 3 978 48,3% 301 7,6% 295 98,0% 17 5,8% 12 70,6% 2,1 1,5 
Vuyani Clinic 33 128 15 189 45,8% 619 4,1% 542 87,6% 110 20,3% 102 92,7% 3,3 3,1 
Klipfontein 169 007 87 030 51,5% 4 986 5,7% 4 658 93,4% 824 17,7% 720 87,4% 4,9 4,3 
Crossroads 1 Clinic 18 955 7 777 41,0% 388 5,0% 375 96,6% 59 15,7% 52 88,1% 3,1 2,7 
Eastridge Clinic 31 767 12 918 40,7% 936 7,2% 931 99,5% 137 14,7% 126 92,0% 4,3 4,0 
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Lentegeur Clinic 31 267 8 077 25,8% 1 089 13,5% 1 043 95,8% 122 11,7% 117 95,9% 3,9 3,7 
Mzamomhle Clinic 66 293 33 673 50,8% 695 2,1% 678 97,6% 159 23,5% 142 89,3% 2,4 2,1 
Phumlani Clinic 34 425 7 733 22,5% 586 7,6% 560 95,6% 150 26,8% 147 98,0% 4,4 4,3 
Rocklands Clinic 12 333 5 785 46,9% 395 6,8% 378 95,7% 52 13,8% 49 94,2% 4,2 4,0 
Tafelsig CDC 52 636 11 591 22,0% 1 598 13,8% 1 424 89,1% 138 9,7% 107 77,5% 2,6 2,0 
Weltevreden Valley Clinic 53 970 32 110 59,5% 864 2,7% 858 99,3% 179 20,9% 165 92,2% 3,3 3,1 
Westridge Clinic 12 412 6 375 51,4% 462 7,2% 454 98,3% 38 8,4% 36 94,7% 3,1 2,9 
Mitchells Plain 314 058 126 039 40,1% 7 013 5,6% 6 701 95,6% 1 034 15,4% 941 91,0% 3,3 3,0 
Bloekombos Clinic 47 859 27 210 56,9% 690 2,5% 680 98,6% 166 24,4% 152 91,6% 3,5 3,2 
Brackenfell Clinic 7 836 5 594 71,4% 101 1,8% 215 212,9% 11 5,1% 10 90,9% 1,4 1,3 
Brighton Clinic 7 425 5 272 71,0% 122 2,3% 120 98,4% 17 14,2% 14 82,4% 2,3 1,9 
Durbanville Clinic 8 211 6 405 78,0% 457 7,1% 453 99,1% 54 11,9% 49 90,7% 6,6 6,0 
Fisantekraal Clinic 12 825 5 214 40,7% 383 7,3% 383 100,0% 56 14,6% 54 96,4% 4,4 4,2 
Harmonie Clinic 9 963 7 044 70,7% 542 7,7% 540 99,6% 56 10,4% 47 83,9% 5,6 4,7 
Northpine Clinic 8 014 6 803 84,9% 44 0,6% 43 97,7% 7 16,3% 5 71,4% 0,9 0,6 
Scottsdene Clinic 7 580 3 528 46,5% 635 18,0% 635 100,0% 116 18,3% 111 95,7% 15,3 14,6 
Wallacedene Clinic 54 414 26 629 48,9% 1 482 5,6% 1 311 88,5% 369 28,1% 342 92,7% 6,8 6,3 
Northern 164 127 93 699 57,1% 4 456 4,8% 4 265 95,7% 852 20,0% 784 92,0% 5,2 4,8 
Alphen Clinic 2 751 2 535 92,1% 23 0,9% 22 95,7% 1 4,5% 1 100,0% 0,4 0,4 
Claremont Clinic 7 059 4 706 66,7% 52 1,1% 51 98,1% 13 25,5% 12 92,3% 1,8 1,7 
Diep River Clinic 4 673 3 136 67,1% 79 2,5% 70 88,6% 6 8,6% 6 100,0% 1,3 1,3 
Fish Hoek Clinic 4 301 3 489 81,1% 40 1,1% 40 100,0% 2 5,0% 1 50,0% 0,5 0,2 
Hout Bay Main Road Clinic 31 488 17 675 56,1% 277 1,6% 266 96,0% 55 20,7% 48 87,3% 1,7 1,5 
Klip Road Clinic 15 112 9 040 59,8% 408 4,5% 405 99,3% 74 18,3% 62 83,8% 4,9 4,1 
Lavender Hill Clinic 11 202 6 005 53,6% 317 5,3% 316 99,7% 50 15,8% 44 88,0% 4,5 3,9 
Masiphumelele Clinic 25 681 15 111 58,8% 485 3,2% 476 98,1% 65 13,7% 62 95,4% 2,5 2,4 
Muizenberg Clinic 3 685 3 060 83,0% 24 0,8% 23 95,8% 3 13,0% 3 100,0% 0,8 0,8 
Ocean View CDC 29 096 8 527 29,3% 838 9,8% 800 95,5% 44 5,5% 38 86,4% 1,5 1,3 
Parkwood Clinic 13 270 3 802 28,7% 256 6,7% 255 99,6% 38 14,9% 37 97,4% 2,9 2,8 
Philippi Clinic 6 242 4 320 69,2% 112 2,6% 111 99,1% 19 17,1% 17 89,5% 3,0 2,7 
Seawind Clinic 21 232 12 844 60,5% 513 4,0% 493 96,1% 80 16,2% 72 90,0% 3,8 3,4 
Strandfontein Clinic 7 584 6 058 79,9% 230 3,8% 228 99,1% 20 8,8% 19 95,0% 2,6 2,5 
Westlake Clinic 5 546 4 310 77,7% 98 2,3% 92 93,9% 16 17,4% 16 100,0% 2,9 2,9 
Wynberg Clinic 8 284 5 682 68,6% 163 2,9% 159 97,5% 31 19,5% 29 93,5% 3,7 3,5 
Southern 197 206 110 300 55,9% 3 915 3,5% 3 807 97,2% 517 13,6% 467 90,3% 2,6 2,4 
Adriaanse Clinic 17 650 9 353 53,0% 1 384 14,8% 1 353 97,8% 135 10,0% 129 95,6% 7,6 7,3 
Delft South Clinic 60 937 23 505 38,6% 2 513 10,7% 2 288 91,0% 311 13,6% 266 85,5% 5,1 4,4 
Dirkie Uys Clinic 15 977 7 899 49,4% 693 8,8% 644 92,9% 61 9,5% 44 72,1% 3,8 2,8 
Elsies River Clinic 16 990 6 123 36,0% 1 355 22,1% 1 341 99,0% 153 11,4% 123 80,4% 9,0 7,2 
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Kasselsvlei Clinic 19 043 11 838 62,2% 1 322 11,2% 1 311 99,2% 124 9,5% 116 93,5% 6,5 6,1 
Netreg Clinic 10 249 5 845 57,0% 771 13,2% 751 97,4% 65 8,7% 35 53,8% 6,3 3,4 
Parow Clinic 13 244 8 620 65,1% 650 7,5% 627 96,5% 64 10,2% 53 82,8% 4,8 4,0 
Ravensmead Clinic 16 846 6 547 38,9% 802 12,2% 768 95,8% 101 13,2% 73 72,3% 6,0 4,3 
St Vincent (CCT) CDC 57 396 23 039 40,1% 1 205 5,2% 1 157 96,0% 114 9,9% 108 94,7% 2,0 1,9 
Uitsig Clinic 13 877 6 693 48,2% 879 13,1% 823 93,6% 86 10,4% 66 76,7% 6,2 4,8 
Valhalla Park Clinic 12 370 6 648 53,7% 7 754 116,6% 734 9,5% 70 9,5% 68 97,1% 5,7 5,5 
Tygerberg 254 579 116 110 45,6% 12 328 10,6% 11 797 95,7% 1 284 10,9% 1 081 84,2% 5,0 4,2 
Albow Gardens CDC 71 223 24 715 34,7% 817 3,3% 728 89,1% 115 15,8% 106 92,2% 1,6 1,5 
Chapel Street Clinic 12 350 2 615 21,2% 208 8,0% 195 93,8% 43 22,1% 34 79,1% 3,5 2,8 
Factreton Clinic 10 246 4 167 40,7% 298 7,2% 290 97,3% 31 10,7% 23 74,2% 3,0 2,2 
Langa Clinic 46 916 25 597 54,6% 555 2,2% 542 97,7% 79 14,6% 75 94,9% 1,7 1,6 
Maitland Clinic 7 797 5 807 74,5% 201 3,5% 198 98,5% 6 3,0% 6 100,0% 0,8 0,8 
Melkbosstrand Clinic 1 769 1 373 77,6% 54 3,9% 53 98,1% 14 26,4% 13 92,9% 7,9 7,3 
Protea Park Clinic 10 897 6 466 59,3% 369 5,7% 357 96,7% 87 24,4% 81 93,1% 8,0 7,4 
Saxon Sea Clinic 8 508 3 723 43,8% 312 8,4% 309 99,0% 61 19,7% 56 91,8% 7,2 6,6 
Spencer Road Clinic 10 649 5 259 49,4% 118 2,2% 114 96,6% 14 12,3% 10 71,4% 1,3 0,9 
Table View Clinic 6 975 4 677 67,1% 37 0,8% 35 94,6% 9 25,7% 9 100,0% 1,3 1,3 
Western 187 330 84 399 45,1% 2 969 3,5% 2 821 95,0% 459 16,3% 413 90,0% 2,5 2,2 
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